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One of the necessary fundamental approaches to an understanding of
malignant growth is the study of normal growth - the orderly proliferation
and differentiation of cells* After w© had considered a number of possible
studies which might be undertaken the objectives of which were thought to
contribute to an understanding of cancer, it was decided to undertake in-
vestigation of some of the chemical agents and biochemical processes incident
to the pathological behavior of the bon© marrow in pernicious anomia. In
pernicious anemia the bone marrow' resembles in many respects malignant
tumors; the amount of tissue increases but it becomes functionally inefficient
The bone marrow cells which would normally develop into the red blood cells
multiply at an exaggerated rate but remain in a primitive form arid cover
mature* The conversion of the tissue from this pathological condition to a
normal state had been shown to be effected by any one of several specific
substances, (a) an erythrocyte maturation factor, (b) an incubation mixture
of an “extrinsic factor*1 and the “intrinsic factor”, (c) folic acid and
(d) thymine. These materials, then, are intimately involved in establishing
the conditions necessary for the normal functioning of at least on© type of
tissue*
Consequently, an extensive and comorehensive research of the literature
was made in order to collect together and correlate the known physiological
and chemical aspects of pernicious anemia (and morphologically related dis-
orders, (with the chemical agents and biological factors which had been shown
to be involved* k summary of this literature research constitutes the first
section of this thesis*
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Daring the assembling of this material there became evident a number
>1 interesting hypotheses which might explain some of the isolated observations
which had been reported* Several of these hypotheses were tested for their
validity and the summary of this experimental work constitutes the second





BIOLOGICAL CHANGES ASSOCIATED WITH PERNICIOUS ANEMIA
Morphological Changes* Most of the pathological conditions involved
in pernicious anemia are associated with distinctive morphological changes
that occur is (a) the peripheral loo! system, (b) the bom marrow, (c) the
mucosa of the m atro-iatoatinal tract, and (d) the nervous system*
the characteristic alteration In the peripheral blood system is usually
the symptom first recognised and is the reason for classifying the disease
as an anemia* This particular anemia is of the macrocytic, hyperchromic
type - a type in which the reduction in the total number of red blood cells
is partially offset by an increase in the size and hemoglobin content of the
individual cells (macroeytosis). In general bn© number of macrocytes can be
correlated with the severity of the anemia* disarre shaped cells can usually
be noted, though they frequently develop only when the disease has reached an
advanced stage* The hemoglobin content of the cells increases in proportion
to the increase in cull size; but there is no hemoglobin "super-aaturstioaH
as is sometimes implied. The "blood picture" is further altered by character-
istic changes in the white blood coll content; the leucocytes elaborated by
lymphatic tissues (lymphocytes) increase in number, but those formed in the
bone marrow (granulocytes) decrease to such an extent that a levered total
unit© count results* The entire alteration in the blood picture (both red and
white cells) characteristic of pernicious anemia is undoubtedly only a secondary
symptom and results from previous changes which have occurred in the bone marrow,
The bane narrow* the tissue In which the red blood cells are formed end
in which they develop, undergoes a change in which there is considerable
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extension of the rod marrow tissue. A large oart of the normally inactive
yellow, fatty marrow is transformed to the red marrow type of tissue; hence
in this disease the bone marrow presents a characteristic appearance of
excessive formation of tissue (s hyperplastic condition)• In addition there
is a striking increase within the tissue of the number of immature* embryonic-
like, red blood cells (megaloblasts) and e decrease in the number of mature
forms (normocytes and erythrocytes)* The diseased marrow itself is many ways
appears to have reverted to as embryonic state. During the remission pro-
duced by appropriate therapy the marrow regains a more normal appearance
because the reverse processes occur, tm amount of yellow fatty marrow increases
the immature cells decrease in number, and there is an increase in the number
of mature cells which can be spilled into the peripheral blood system.
Malfunctioning of the mueoga of tae gaatro-lptestinal tract is probably
the initial cause of the pathological changes occurring in the bone marrow*
In true orniclous anemia, this mucosa, particularly the gastric portion,
atrophies, markedly reducing the patient's secretion of gastric juice*
Achlorhydria (failure to secrete free hydrochloric acid) even following a
subcutaneous histanine injection, is a characteristic symptom* Essenticily,
however, the direct cause of the development of pernicious anemia is probably
the inability of the patient to elaborate and secrete a specific substance, a
component of gastric juice designated tnc "intrinsic “actor". Extensive
histological studies have been made to determine which gastric cells ere re-
sponsible for the accretion of this intrinsic factor and thus to local!»e the
site of degeneration which leads to pernicious anemia* following the de-
monstration by Sharp (1), and Isaacs and Sturgis (2) of the existence of this
factor in the stemoh lining of swine, several Investigations were carried out
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using the linings of hog stomachs and intestines to further characterise the
intrinsic secretory cell, Peulengracht (3) using swine localised the active
substance in the glands at the stomach-small intestine junction (pyloric
gland organ), the cells in the body (fundus) of the stomach being active.
Activity was also shorn to be present throughout the entire small intestinal
tract, however* a histological study of stomachs from pernicious anemia
patients showed little or no apparent change in, the pyloric type cell, but
definite degeneration of the fundus type# This was confirmed by Fox and
Castle (4). whatever the nature of the gastric lesion which causes this
decreased ability to secrete the intrinsic factor, it dees not appear to be
the end result of an inflamatory process (5).
Frequently, the conditions just described are accompanied by an involve-
ment of the nervous gysteal, a degeneration of a portion of the spinal cord
(subacute combined degeneration). The extent of nervous involvement does sot
necessarily parallel the severity of the anemia; hence it is not regarded as
merely a consequence of the anemia itself but is believed to be directly re-
lated to the primary factors responsible for the disease. Degeneration in
tne peripheral nervous system has also been demonstrated to occur in per-
nicious anemia. .Incoordination and the loss of vibratory sensation, usually
in the lower extremities, are the symptoms of nervous system impairment most
often observed.
i'hyaiological Changes* The primary physiological disturbances which
can be demonstrated in pernicious anemia all result fros the decrease .in
gastric juice secretion. This reduced secretion is directly responsible for
the following chemical changes which ensue: (a) the process "catalysed* by
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the "intrinsic factor" of the gastric juice no longer proceeds at a rat©
adequate for the needs of the patient; (b) an achlorohydris occurs; (c) the
liver becomes depleted in a substance(a) designated as the erythrocyte mat-
uration factor* In addition, a number of secondary changes in the patient* s
metabolism are reflected in alterations which can be demonstrated by che ical
tests, but which cannot as yet be logically correlated with the primary
disturbances induced by the gastric lesions* The best characterised examples
of such changes which occur ares (a.) alterations in porphyrin metabolism,
(b) a defect in tyrosine metabolism; (c) a decrease in the choline ©terase
activity of serum and red blood calls; and (d) abnormal concentrations of
cholesterol in the blood plasms..
The ability of the gastric mucosa to secrete the essential "intrinsic
factor" appears to be irretrievably lost, necessitating the constant treat-
ment of the oatlent* Reports of the return of normal gastric function follow-
ing treatment have appeared frequently in the literature; however, the
tendency at present is to question the diagnosis of these cases as true
pernicious anemia* Likewise, achlorhydria, even following histamine in-
jections, has been found to be a constant feature, both before and after
remission in all cases where an adequate and thorough study has bean made
(6, 7,8).
It ban been demonstrated that the liver stores an erythrocyte maturation
factor, necessary for the normal functioning of bon© marrow. Depletion of
this (9, 10) factor in the liver precedes the development of those pernicious
anemia symptoms which are reflected in the hematopoietic picture* Extracts
prepared from livers of pernicious anemia patients in relapse, when tested
clinically, lacked any anti-anemia activity. If, however, the liver extracts
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were obtained from specimens of patients in whom the anemia had boon relieved
fey therapy, the erythrocyte maturation factor was present.
Altered porphyrin metabolism in pernicious anemia is apparent* Bili-
rubin is present In the blood plasma in significantly increased amounts (11),
and the concentration of urobilin and urobilinogen in the feces, duodenum,
and urine is increased, a condition usually considered to be indicative of
a hemolytic anemia. In support of this concept that hemolysis occurs during
pernicious anemia, 1® the fact that red blood cells of treated and untreated
pernicious anemia patients have been transfused into normal individuals and
the coll survival time noted. The calls from the untreated patients had a
shortened survival time, waich may be taken ss the criterion for a true
hemolytic syndrome (12)•
Coprouor >hyrin I excretion increases during periods of relapse and
decreases following remission* Thus, the excretion inversely parallels
hematopoiesis, snd the amount excreted can be taken as an index (inverse) of
the blood regenerating activity* It has been found that whenever hyperplastic
bone marrow is present there is a similar increase in coproporphyria I
excretion* The reason for this relationship, however, remains obscure. Two
separate line® of porohyrin synthesis (the so-called "dualism* of porphyrin
ssetaholism) exist in man, giving rise to etloporphyrla X and stioporphyrin lII*
Hemstin is derived from etioporphyrin XII, but without complete disruption of
the poruhyrin ring It is impossible to conceive of etioporphyrla 111 becoming
converted to ©tioporphyrln I* Hence the experimentally observed relationship
between the apparent reduced production of heoatin and the increased formation
of coproporohyrin I is not obvious*
Detect ion of an increase in blood phenols among pernicious anemia patients
has been reported (13)* More recently a new study was undertaken in which it
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was found that among untreated patients there Is an increased excretion of
keto acids arid hydroxyphenol acids* Following therapy, tne amount of these
substances excreted returns to normal* The disturbance is apparently in the
tyrosine metabolism (14)*
Serum and red blood call cholinesterase activity has been consistently
shown to be decreased in pernicious anemia patients in relapse; normal
activity values are obtained following the response after the institution
of adequate therapy (15, 16, 17)*
Similarly the free cholesterol in the plasma of the pernicious anemia
patient is reduced but is restored to the normal level during remission
(18, 19)* Although free cholesterol Is diminished in the red blood cells,
esterlfied forms are present in excess of the usual range (20)*
Decreased lecithin phosphs te in blood plasma frequently occurs | other-
wise no other consistent changes in fat metabolism have bean noted* The
suggestion has been made that this alteration in fat metabolism sight be
related to the degeneration of the nervous system (21)* The question arises
whether this decrease is a non-specific secondary metabolic upset, such as
one might expect to occur as a result of the primary alteration in the
hematopoietic system (e* g., like negative nitrogen balance, altered
sugar values) or is an effect due directly to a lack of the anti-pernicious
anemia factor* Because of the lack of parallelise between the severity of
the nervous and hematological involvements one is tempted to postulate a
direct, separate influence of the anti-pernicious anemia factor upon each of
these systems, and henoe possibly a participation of the anti-pernicious
anemia factor in phospholipid metabolise*
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B.
AGENTS USED IN THE TREATMENT OF PERNICIOUS ANEMIA
Diet bad long been considered as a possible factor involved in per-
nicious anemia, but until 1926 had received no intensive investigation*
Noting the favorable results obtained with liver in %he experiments of
Whipple and Robscheit-Robbins (effect of diet upon blood regeneration follow-
ing acute hemorrhage) (22), Minot and oorphy in that year treated a series of
45 pernicious anemia patients with a special diet in which liver was a
prominent factor (23)* The responses which they obtained established the
therapeutic value of liver and initiated the attempts to concentrate the
active fraction from the whole liver. Some degree of concentration was soon
effected, but it was not until 194 S that the isolation frost liver of a
crystalline compound possessing anti-pernicious anemia activity was announced
(24).
These preparations from liver are usually administered uarentarally*
whan given orally a much greeter amount of the active material must be given
to elicit the same clinical response (25)*
In the meantime, Castle had demonstrated 'that mucosa of the stomach
normally secretes a substance (the *intrinsic factor*) which acts upon an
unidentified dietary material (the "extrinsic factor") to produce an intax**
mediate substance which was believed to be ultimately converted to the
erythrocyte maturation factor found in liver (26, 27, 28)* Consequently, the
therapeutic value of dried stomach preparations was tried and established by
the work of Sturgis end Isaacs, and Sharp (1, 2)* Thus it is possible to
alleviate the deficiency not only by the parenteral injection of the erythrocyte
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maturation factor but by supplying orally an exogenous source of *intrinsic
factor*. Commercial preparations of the "intrinsic factor* vary, some contain
the dried stomach mucosa only, others Include dried liver concentrates.
In addition to these two substances, a third agent, folic acid, was
found to produce definite remissions in pernicious anemia patients. Folic
acid is a nutrilite that was discovered and isolated solely on the basis of
its growth promoting effects on microorganisms. Later, tested clinically,
it was found to stimulate a striking hematopoietic response in pernicious
anemia patients (29, 30, 31)* The amount of folic required to obtain remission
is relatively largo in comparison with the amount of liver extract which is
affective. Ho eases responding to liver extracts have been reported in which
adequate folic acid therapy could not also produce a hematopoietic response,
but it has been observed that folic therapy does not prevent the development
of the neurological symptoms, nor does it arrest the development of those
neurological symptoms which may ha already present (32).
A number of derivatives chemically related to folic acid have been
tested for their hematopoietic activity. Those which have been reported to
be active in macrocytic anemia are* (a) pteroyl-e-glutamylglutamic acid (33),
(fe) pteroyl-Y-glutasqrl-Y-glutesiylglutaaic acid (34), pta^oylh&xaglutamyl
glutamic acid (34), end (d) formylfollc acid (35)* Hona of those compounds
show more activity than folic acid.
Thy'tine* a pyrimidine constituent of thynonuelelc acids, can partially
replace the folic acid requirement of certain microorganisms. Consequently,
it and related compounds were tested clinically. Only thymine, could fee
demonstrated to have any anti-parniclous anemia activity (32).
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In the fallowing discussion, it has been found convenient to divide
these therapeutic agents on the basis of both their chemical and functional
natures Into three groups} (a) the agents directly related chemically to the
factor Isolated from liver, (designated as erythrotln or vitamin or sub-
stance® involved in the formation and utilization of this vitaminj (b) coot-
pounds derived from folic add (pterins and jg-aminohenzoic acid, containing
compounds); and (c) nucleic acid components (nucleotides, nucleosides,
purines and pyrimidines)* .In addition to pernicious anemia, there are a
number of other disorders which have been found to respond to certsln of
these agents* Some of these pathological conditions are obviously related
physiologically to pernicious anemia by virtue of their also feeing macrocytic
anemiasi in others the relationship, if any, is only apparent In that they
have 'therapeutic agents in common with the macrocytic anemias*
C.
PATHOLOGICAL CONDITIONS RELATED TO PERNICIOUS ANEMIA
Although from the standpoint of treatment, oeraiclous anomie can be
classified as a deficiency disease, it is not a deficiency is the usual sense
inasmuch a* it does not arise' from an Inadequate dietary regime. True nut-
ritional deficiencies, which result in similar anemias, however, are recognized
Thus, Mill* (36) showed that tropical macrocytic ameia could b© trassted
toy suoplementing toe inadequate diets with marmite, an autoload yeast
preparatlon. At first this lype of anemia was believed to occur predominantly
among pregnant women, but later investigations showed it to be more general
in distribution, foe alterations observed in tae peripheral blood
stream and in the bone marrow are characteristic of thorn present in
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pernicious anemia. However, the relative rarity of subacute combined, spinal
cord degeneration and (the absence of an increased occurrence) of achlorhydria
among these patients distinguish the tropical macrocytic anemia from per-
nicious anemia. Because of the marked similarity to pernicious anemia, liver
extract therapy was tried. Satisfactory hematopoietic responses occurred
only as long as the less purified preparations were used, indicating that
these two types of macrocytic enemies differed in their response to thera-
peutic treatment (37, 38).
A macrocytic anemia sometimes occurs during pregnancy. As in psiv
nicions anemia, a megaloblastic, hyperplastic bone narrow is constantly
encountered, and though subject to son* variability, the peripheral blood
picture is usually similar to that found in pernicious anemia. At first con-
sidered to be of nutritional origin, this condition was later shown to be
present among individuals eating apparently adequate diets. However, as in
tropical macrocytic anemia, cases hav© been reported which were refractory
to purified liver extracts (rich in vitamin but which responded to the
administration of folic acid (39). Termination of pregnancy is followed by
realsstar of the anemia without the continuance of therapy. That the anemia
might be the result of an increased need for folic acid occasioned by the
fatal demands upon the mother may be postulated and this could also account
for the long lag between the institution of therapy and the beginning of
remission. Certain discrepancies, however, remain to be answered. Thus, why
will orally administered liver extract sonatinas succeed in relieving the
anemia where parenteral administratis® failed (43)? Also what evaluation should
be given to the evidence that In sane cases secretion of the factor11
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apparently ceases but returns following parturition (41)?
Correlating evidence for the inadequacy of the erythrocyte maturation
factor to function in replacing folic deficiencies has been obtained through
the use of experimental animals* Reports have >een made concerning the
inability of folio-free liver extracts (rich in vitamin to replace the
need for folic acid in nutritional deficiencies (42* 43)in the deficiency
induced in rats by succinylsuLphi?this*ole (44)* and in the deficiency
induced by i-aethylfolic acid in dogs (45)#
Scrue* idiopathic steatorrhea* and celiac disease prepent similar
clinical pictures usually showing certain symptoms common to the macrocytic
anemias# In these disorders* however* there is a marked intolerance for
fats* and often for carbohydrates, and diarrhea is a predominant sym-tom in
most oases# k characteristic distortion of the intestinal mucosa is usually
revealed by roentgenographlc examination of the intestine# This pathological
development results in a decrease in Urn absorptive capacities of the in-
testinal mucosa* a condition which can bo demonatrated by a glucose
tolerance test (46)# Decreased absorption of xylose can also be demonstrated
(47).
Sprue is usually classed as a nutritional deficiency* However, it
seems to occur among both the well-to-do and the indigent; in fact, Ashford
reports the disease to be more roainent among the former (4s)* The nutritional
deficiency undoubtedly arises as a result of the decreased intestinal ab-
sorption* But it cannot definitely be stated that this intestinal change is
the. result of rather than the cause of the deficiency*
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The peripheral blood picture in sprue may be either that of a bypo-
chrcnic, microcytic anemia (as in iron deficiency)(49) or of a macrocytic
anemia (50). The latter ie more common ami is identical with that found In
pernicious anemia* Cases have been observed where microcytic snettles have
given way to macrocytic anemia. Leukopenia frequently accompanies the
macrocytic anemia*
Bom marrow fro® cases with microcytic anemia typically contains no
magaloblasts while marrow from patients with macrocytic anemia has the megalo-
blastic appearance encountered in pernicious anemia* Generally sprue cases
are mt seen until 'well advanced* It is possible that the incidence of
aecrocytic anemia in sprue would be less If the cases were detected in the
early stages of the disease*
Probably the macrocytic anemia of both sprue and pernicious anemia
results from a lack of the erythrocyte maturation factor. In the latter
dysera ala this lack, is attributed to the failure of the individual to secrete
the "intrinsic factor" necessary for the utilisation of the dietary "extrinsic
factor" which is elaborated into the erythrocyte maturation factor* The de-
ficiency in sprue, however, arises not from inability to produce the
erythrocyte maturation factor, but from defective absorption*
Achlorhydria is not & consent fea ture of sprue, arid even among those
eas«s in which the absence of free hydrochloric acid accretion has been re-
ported are some in which secretion has returned following therapy (51)*
Unlike pernicious anemia, adequate production of factor3 takes
place in all eases of sprue* Those esses in which its presence cannot be
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demonstrated should be classified as pernicious anemia. This indicates the
difficulty sometimes encountered in differentiating one dyecrasia fro® the
other.
Sprue appears to be a disease entity in which aither folic acid or
liver extract (containing vitamin can be used with satisfaction. After
remission adequate dietary therapy should still be maintained, since a low
intake of fat is necessary to prevent the steatorrhea (52, 53)* Once the
anemia has been relieved, the intestinal absorption usually ia roves and the
administration of the hematopoietic substance can be discontinued. Relapses,
however, are likely to occur unloss there is strict adherence to the diet
restricting fats and carbohydrates.
It is interesting to note that only rsraly have cases of sprite hcan re-
ported to have the spinal cord degeneration found in pernicious anemia (54)*
This fact coupled with the effectiveness of either folic acid or liver extract
therapy would appear to place sprue intermediate 'between tropical macrocytic
anemia and pernicious anemia from the standpoint of the chemical factors
involved in precipitating the pathological conditions.
The nutritional deficiency of an "animal protein factor% bow shown to
be identical with the vitamin (55, 56 ) t has been noted to occur in
chicks (5?), rats (5B), and mice (59)* Anemia, leucopenis, decreased growth
rate and death re stilt from a lack of this factor, and it has been demonstrated
that folic acid cannot be substituted for this factor in the treatment of
these deficiencies (s*?)* Death in the weanling rat appears to bo due to
hemorrhage in the fundic portion of the stomach.
There has bmm no clear cut demonstration of a nutritional deficiency
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of the •extrinsic factor% Inadequate intake of this factor has been postulated
as a contributing factor in those cases of pellagra exhibiting a macrocytic
anemia* Usually, however, the deficiency In most pellagrans is of such a
multiple nature that the clinical pictures have few constant features apart
from certain characteristic skin and ancons membrane lesions* In sene
Della grans a diminished secretion of the •intrinsic factor*1 has been reported
(60).
While macrocytic anemia .1® not a prominent feature of fish tapeworm
(Diphyllobothrium la tom) infestation, when, this symptom is present, it gives
a clinical picture very similar to that of pernicious anemia* Spinal cord
involvement is rarely encountered* Response of this type of anemia to liver
extract therapy is similar to that for pernicious anemia*
Certain anomalies have been observed concerning the development of a
macrocytic anemia following infestation by the fish tapeworm* The Incidence
of macrocytic anemia is not always proportional to the extent of the infesting
worm population* Armas where pernicious anemia is more common have a higher
rata of the macrocytic anemia associated with worm infested persons* Familial
tendencies have also been noted* This associated anemia might thus be but a
matter of coincidence, where infestation and pernicious anemia have occurred
simultaneously; or possibly there exists a constitutional predisposition to
pernicious anemia among those in which the condition develops, which would not
have bean detected had they not been Infested by the tapeworm (61).
If the parasite is responsible, the problem of how the mmala is produced
must be answered* Interference with gastric secretion, interference with
absorption, or removal of the erythrocyte saturation factor have all been
suggested as possible mode© of action* Recently the location of the infestation
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has been reported as relevant to the development of anemia, macrocytic anemia
resulting only whan the parasites inhabit the small intestine (62).
In stonech carcinoma one night expect interference with the normal
secretory functions of the stomach* Thus a lack of "intrinsic factor* can
be postulated as the basis for the .relatively few cases of macrocytic anemia
observed to occur as a consequence of stomach carcinoma, and relieved by
parental injection of liver extract (63, 64, 65)* There is evidence of a
significantly higher incidence rate of stomach carcinoma among persons treated
for pernicious anemia than there is among persons free of this dyserasis
(66, 67)*
In man the secretion of “intrinsic factor” occurs mainly in the fundic
portion of the stomach. For pernicious anemia to result from gastrectomy,
it would have to be total and Include trie entire cardiac region. Xt is the
opinion of bethell, 3t si.. that following total gastrectomy rerniclous
anemia will eventually develop (68).
Casas of partial gastrectomy and gastro-enterostomy have been reported
to result in a macrocytic anemia, the number, however, when compared to the
total number of such operations performed is relatively small.
Among ta© cases of fully developed intestinal strictures or anastomoses
are mmny which present a clinical picture typically that of pernicious anemia.
The peripheral blood pictures are identical? a hyperplastic, megaloblastic
bona marrow is present! leucofsenla is eaaaon; however, the neurological in-
volvements are not pronounced* As might be anticipated, achlorhydria is not
a premineat feature, nor is there a decrease in the excretion of "Intrinsic
factor 11 (69)• Cases have been reported in which operation for correction of
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the intestinal condition has resulted in relief of the anemia (70)* De-
ficient absorption would eem the logical explanation! however, studies have
shown glucose and fet absorption to be relatively good* Ob the other band,
the liver extracts which arc used to relieve the anomie Bust be given
parmntemllf since oral administration is ineffective.
Tm extent to which macrocytic anemia occurs in association with liver
disease remains In doubt* In rats with a carbon tetrachloride induced
cirrhosis of the liver, a progressive development of macrocytic acedia has
been noted as the cirrhosis increases (71)* Reports on macrocytic anemia
accoapanylng liver disease in Mats show a variation fro® an 0 to 91 percent
incidence (72, 73)* The anemia never becomes bb severe as it does in per-
nicious aft«»t** Clinically the sy*ptons are generally those associated with
the liver disease rather than the anemia* Achlorhydria was found in only
40 percent of the cases with macrocytic anemia (74)* On trie basis of the
report-3d ability of liver to store the erythrocyte saturation factor, trie
suggestion was .made that inability to store this factor is the precipitating
factor in development of a macrocytic anemia* However, extracts prepared
from diseased livers of patients in whom there had been an accompanying
macrocytic anomie showed anti-psrnlclous anemia activity whan tested clinically
indicating no impairment of storage ability {7s}* Alternatively, it is pro-
posed that the erythrocyte .maturation factor Bust be acted noon in some mnmr
by the liver. This would account for failure of the annals to respond satis-
factorily to liver extract therapy (76, 7?). Cases have, however, been re-
ported in which the anemia does respond to liver extract (73, 74),
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In Addition to those maeroeytie anemias, another, designstod achrestic
anemia, has been described in which the morbid anatony is similar to that of
pernicious anemia, but which is unrelieved by either liver extract or folic
acid therapy (79)* Unlike pernicious anemia, subacute combined degeneration
of the spinal, cord does not occur. Also free hydrochloric acid can be
demonstrated in the gastric juice. Liver extracts prepared from several of
these eases were demonstrated to contain the erythrocyte saturation factor.
Apparently this is a condition in which the bone marrow becomes mega-
loblastic not from a lack of the erythrocyte maturation factor but from an
inability to us© it.
D.
THE CHEMICAL NATURE OF THE THERAPEUTIC AGENTS
USED IN THE TREATMENT OF MACROCYTIC ANEMIAS
Many attempts have been made to clarify the character of the intrinsic
and extrinsic factors and the nature of their reaction. A prime difficulty
in their character.!nation lias been lack of an adequate, accessible means of
assaying for activity.
intrinsic factor* In general an enzymatic character la proposed for
the intrinsic factor* Aoong its rotein-like attributes, the following can
be listed: (a) thermolability (destroyed by boiling neutral solution for 5
minutes, by holding at a temperature of 70-80#C. for one half hour or at
40*€. for three days), (SO) (b) destruction by autolysis of gastric juice,
(c) destruction by prolonged digestion with pepsin or trypsin (81), (d) pre-
cipitation by saturation with ammonium sulfate, (e) non-dlalysable, (f) non-
ultrafilterable, (g) about 50 percent adsorption at pH 7.4 fey an amount of
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Lloyds reagent required for com Ist* removal of pepsin and remiin from the
gastric juice (82, 83). More recently a report has been made that contrary
to the above work the intrinsic factor is ultrafilterable (84).
Studies nave been made on the proposal that the intrinsic factor
possesses proteolytic activity (85, 86, 89, 88), but no definite information
has been obtained, kgron believes the intrinsic factor to be identical with
aminopolypeptidase on the basis that they appear to be concentrated in
perallel (89). Anderson and Faber, however, were unable to confirm Agren*s
work (90).
Pxtrlnaio factor. In contrast to the intrinsic factor, the extrinsic
factor appears to be a highly stable substance. Thus it resists autoclaving
for five hours at 15 lbs. pressure (91), hydrolysis with dilute sulfuric acid
(91), end treatment with alkali (92). Dilute acetic acid has bean used to
prepare extracts from musole which contain extrinsic factor activity (92).
It is also soluble in 80 percent alcohol (91).
Several materials have been tasted for their content of extrinsic
activity. Due to the limitations imposed by the assay procedure, extensive
surveys have been impossible. Many of the negative results reported prior
to 19% mist be discarded following the experiments of Castle end Ham (93)
in which they showed that prolonged incubation at too high hydrogen ion con-
centrations resulted in a loss of activity.
Since one or more ambers of the 8 vitamin eoaj&ex might constitute the
extrinsic factor, Castle, et al. (92), tested the following combine aion of
substances! thiamin, riboflavin, nicotinamide, pyridoxin© hydroohlorid©,
calcium pantothenate, para«a»inobenzoic acid, choline hydrochloride, inositol,
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biotin, xanthopterin and folic acid. Mo indication of extrinsic activity was
discernible.
bgg white (94) , Cohn* s liver fraction *G** (95), autolyxed yeast, rice
polishings, wheat germ (96), and crude casein (99), in addition to beef
muscle have bean found to contain the extrinsic factor, least has bean a
particularly controversial source. Wills (98) proposed that autolysis of
yeast was necessary to release the extrinsic factor. The question concerning
autolysis is complicated since there also is a question ns to whether or not
yeast in the absence of the Intrinsic factor has hematopoietic activity. The
number of contradictory results led Wintrobe to conduct a more comprehensive
investigation of the situation. In trials with fifteen case?®, he found
dried brewer* a yeast yielded a maximum response in five cases. A sub-
maximum response was obtained in only two cases, both of which were also
later found to respond inadequately to liver therapy#(Baker*s yeast and
extracts therefrom proved to be unsatisfactory)• Amounts of beef, equivalent
on a protein bests to the brewer*s yeast, when fed to five patients elicited
no response in four, the fifth individual responded but also gave an ad-
ditional secondary response when fed yeast# Incubation of dried brewers*
yeast with gastric juice effected an increase In activity comparable to that
obtained when liver was similarly Incubated. (99)# In view of the responses
subsequently obtained with folic acid, it becomes apparent that part of the
observed activities could be attributed to this compound#
infraction between the intrinsic and extrinsic factors* the nature of
tbs reaction between the postulated extrinsic and intrinsic factors has thus
far not been found. From Castle's experiments (93) it is apparent that
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contact between the two factors is necessary. Thus if they arc fed separately
and an interval of longer than six hours Is allowed to lapse between their
adrainiatr tion, no activity can be demonstrated.
The reaction itself appears to occur normally in the gsstro-intestinal
tract. It was found that a pH from 5-7 furnished consistently better results.
A low pH or a prolonged incubation of mixtures containing the two substances
yielded inactive material (91).
Greansoon (100) suggested that the pepsin in an acid medium inactivated
the intrinsic factor and that the role of the extrinsic factor during incubation
was to remove or inactivate the pepsin, thus protecting the intrinsic factor
and leaving it potent and intact. However, after the intrinsic factor and
pepsin have been separated, the former continues to be inactive unless it can
contact the extrinsic factor.
The production of anemia by fish tapeworm infestations is related to
the location of the parasite in the intestine. Whan there is appreciable
infestation of the small intestine a macrocytic anemia is usually present.
In each cases, where there is no deficiency of cither the extrinsic factor in
the diet or of the intrinsic factor in the gastric secretion, there must be
either (a) a further transforms tion involving an Intestinal factor which can
no longer take place due to the infestation; or (b) a removal or destruction
by the parasite in the intestinal tract of one of the components or inter-
mediates of the system involved in producing the erythrocyte maturation factor.
Efforts have been aerie to obtain the erythrocyte maturation factor
from incuh~s tion sixtores of extrinsic and Intrinsic preparations. The results
do not appear to be decisive in demonstrating either the success or failure
of those attempts. On the basis of Castle's work it would appear that
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in vitro incubation does not yield the erythrocyte maturation factor; and
he has postulated the formation of a thenaolablle intermediate (101).
Klein and Wilkinson (102), however, reported the preparation of a
thermostable extract from an incubation mixture using the mrm methods that
have bees employed for the preparation'of potent liver extracts. Their
intrinsic source was the press juice of hog stomach which they had fractionated
After six hours of incubation at 3r
’cC., a clear liquid was separated from
the mixture (150 g. fresh beef, 5 g» stomach fraction) and heated to 60-65®C.
for a period of thirty minutes. When tested by oral administration, this
liquid preparation was found to be active. The unheated stomach fraction
was active by itself, but after comparable heating no response was obtained
when it was administered either alone or following a six hour incubation
with fresh beef. Ikes# results point to the formation of a distinct re-
action product.
Supplementary evidence along the same line was supplied % Kyer, Brooks,
and Isaacs (103). using desiccated stomachs they prepared acid and aqueous
extracts. Heating these extracts to 6Q-?Qc ‘C. for one-half hour inactivated
them. let, if the acid extract were allowed to incubate eight hours at 3?®C.
before such heatings, the preparation remained active, although it was pos-
sible to inactivate the active principle fey raising the temperature to the
boiling point.
Attempts to prefsare an active erythrocyte maturation factor extract
from dried swine stomachs using the concentration methods employed In man-
ufacturing liver extract preparations have been reported as unsuccessful (104)*
Mass* has reported (105) the preparation, of a thermostable erythrocyte
saturation factor by incubation. In this ease also (as in Wilkinson*a report)
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press juice of macerated hog gastric mucosa membrane was used as the source
of the intrinsic factor. Ox muscle was used to suooly the extrinsic factor.
Following incubation at 37*0*, the formation of a thermostable anti-pernicious
anemia factor was claimed.
Rossi (106) incubated a filtrate fraction obtained from yeast with
human gastric juice. Tented separately neither the yeast extract nor the
gastric juice showed hemopoietic activity, but by incubating them together
{ 6 hours at 3""®C.), activity was developed* The active principle w&s heat
stable, soluble .in 70 percent alcohol and insoluble in 90 percent alcohol.
Working with dried stomach preparations presents several disadvantages*
In general such preparations contain g sufficient amount of extrinsic factor
to show hematopoietic activity alone* Bor can one rule out the possibility
that these preparations might contain Intermediary reaction products* The
intermediary reactions which take place between the Initial incubation of
extrinsic and intrinsic factors and the final formation of the erythrocyte
maturation factor as it is isolated from liver regain unknown* The evidence
cited, gives some basis for believing that the initial reaction between the
intrinsic and the extrinsic factors occurs anterally and that an additional
intestinal factor may be involved*
Jacobson (10?) reported finding the absence or marked diminution of
argentaffin* colls from the gasiro-intestinal tract of pernicious encode
patients* (103) separated the layers of hog duodenua and tested
them clinically* He found(in accordance with Jacobson*s postulation) that
the exterior fraction consisting of the villi (Including argentaffins cells)
and crypts of Lieberkuhn (99 percent) end Brunner*s glands (1 percent) gave
a hsmwtcfotstlo rsspouse* Us intermediate lay#* (66 pereeat IrasuHr1! gltsds
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and 1-2 percent villi and crypts), and duodenum muscle layer war© both without
hematopoietic activity. £t is possible that these argentaffins cells serve
as the sit® for (a) the formation of either the thermol&bile intrinsic factor
itself, or for (b) the production of a relatively thermostable Intermediate
in the formation of the erythrocyte maturation factor, or for (c) the final
reaction in which is famed the erythrocyte maturation factor itself*
While the ait® of secretion and the site of reaction do not necessarily
coincide, it is hardly probable that the reaction site would be located above
the secretion site*
erythrocyte maturation factor* The erythrocyte saturation factor is
very heat stable and will withstand autoclaving for five hours at 15 lbs*
It is both acid and alkali labile*
Concerted efforts were made to isolate the active principle from liver
preparations* From the study of Cohn and collaborators (109)it was suggested
that the active component Mas a nitrogenous base having a low nitrogen content
(conditions excluding such possibilities as purines and pyrimidines)* Oskin,
tingley, md Meet (110) postulated that the erythrocyte maturation factor was
s peptide or at least associated with a peptide* Karrer, Frei, and Fritssch®
(111) reported m active preparation which contained no phosphorous, pentose,
flavin, pterin or reducing carbohydrate* Subb&How, Jacobson, and flake (112,
113) obtained results indicative that actually a combination of Wo or more
substances yielded more successful therapeutic results* On tm basis of this
experimental work, a multiple factor hypothesis was evolved* Later trials
indicated that there was a primary hematopoietic factor in liver sad in
addition at least three accessory factors (114)* A complex purine, a peptide
a,4 i-tyrosine have been postulated as composing these accessory factors*
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Other groups have also postulated the probability of acre than one
factor. Sisler, Hammersten, and Theorell (115) separated liver extract into
two portions, one of which initiated the production of young, reticulated red
blood cells (reticuloeytosis) and the other, when administered with the first,
caused their further development into normal red blood cells. The fraction
stimulating reticulocyte formation could be replaced by definite chemical
compounds, as, for example, the protein-free salt of thymonuclelc acid.
Wlchels arid Hofer (116) similarly separated a reticulocyte factor from
preparations possessing a general curative activity.
4 crystalline erythrocyte maturation factor was finally isolated in
the spring of 1943 (24> 24s)* This material was active clinically in vgju
amounts* It was described as small, red, needles which darkened at 210-220®C*,
but did not liquify below 300®C* Mission spectrographic analysis showed the
presence of cobalt* Mo sulfur, but phosphorous and nitrogen are present in
this cobalt complex. The absorption epeetrim correspond* to those of a
porphyria compound. Using micro-biological assays, it was shown that this
compound la destroyed by standing at room temperature for 23 hours in dilute
acid (G.GGI H) or alkali (0.015 fO(U7).
Folic acid* Wills’ observation 4b 1932 (36) that israits could be
effectively used to relieve tropical macrocytic anemia was probably the first
concerned with a biological effect that could be attributed to what wo now
know is folic acid. It was found that an analogous deficiency could be
obtained experimentally by subjecting 'donkeys to a similar environment (118,
119), Cytooenia, s reduction in the number of circulating blood colls,
was the predominant feature, and was the criterion which gave the most accurate
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estimate in animal assay procedures, the factor necessary to alleviate the
deficiency was termed vitamin M (120# 121)•
In 1940, Snell and Peterson (122) reported that an unidentified factor
was necessary for the growth of Lactobacillus easel, and they termed it the
’•norite slue to factor”. The sa*ae year the importance of vitamin as a
dietary factor which prevented chick anemia was also announced (123). The
following year it was found that concentrates of the •’norite eluate factor11
were also active in promoting the growth of Streptococcuslßeealls R (formerly
known as Streptococcus lectia R)(124)• k highly refined preparation of &
factor prepared fro© spinach by Mitchell, Sne.ll and Williams and designated
as folic acid was shown to be the active principle promoting the growth of
Lactobacillus easel arid. Streptococcus faecails R in a medium which was other-
wise well characterised (125).
h crystalline preparation of the chick anti-anemia factor (vitamin B^}
was isolated in 1943# and its activity ss a growth factor for both Strop*
toeoocus faec&lls S and Lactobacillus easel was demonstrated. Hence it was
postulated and subsequently demonstrated that the aicro-btologieal activity
of the norite aluate factor and folic acid were identical with each other and
with vitamin (126). The structure of this vitamin was shown to be
c
B-pteroyl-L-glutamie acid In publications which simultaneously announced the
proof of its structure end its synthesis (127, 128).
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S-pteroyl-L-glutamie sold
Broken down into its component parts# the folic acid molecule is com-
posed of (a) ait aminafaydroxypterin (related to xanthopterin) connected by a
methylene bridge to (b) jg-sml&obensoie acid which is linked by a peptide
bond to (e) glutamic acid. Significant physiological activities had previously
been ascribed to eaten of these three component parts.
■Xanthopterin* The hematopoietic effects of this compound have been
observed on a number of occasions* It effectively relieves the anemia of
baby rats nursed on goats1 milk (129)# and an anemia in young Chinook salmon
(130# 131)* Alleviation of vitamin M deficiency (i* s. folic acid deficiency
in the monkey) by xanthopterin has also been reported* The effect here,
however, is only temporary and is also incomplete (132)* Reports that
xanthopterin stimulates the rate of cell proliferation (both red blood cells
and nucleated cells) in bone marrow suspensions have teen mads* Similar
results have been noted in nutritionally anemic rats. The amount of pterin used
seams to be critical; above a certain concentration the compound loses its
stimulatory capacity and becomes inhibitory (133)*
k% om time It was thought that xanthopterin could bo used by liver
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phenomenon indicated, that the xanthopterin acted not as a precursor of folic
acid but rather as an agent which spared the destruction of folic acid by
competing with it for a pterin degrading ensyme (116)# The sparing action
thus postulated could account for the hematopoietic effects noted. The
inhibitory effect of an excess of xanthopterin could be explained upon the .
same basis for its presence in amounts in excess of that needed to produce
the sparing effect would undoubtedly cause it to compete with folic acid for
a place in the enxyme systems in which folic acid functions.
Xanthopterin has also been reported to inhibit the development of
tumors (117, 118), an observation which may bo related to the inhibition of
Rous Chicken Sarcoma by a nutritional deficiency of folic acid (139,140)*
Acid* The biological role of this compound was first
recognised through its ability to prevent the sulfonamide inhibition of the
growth of mi cro-organisms. It was .postulated that the sulfa drugs exerted
their activity by competing with jg-aminobensoic acid for an enxyma system
(141, 142). Subsequently it was shown that yeast extracts could be used to
reverse the sulfonamide inhibition* The isolation of jg-amiuobensoic acid from
those yeast extracts established its natural occurrence (143)*
After the elucidation of the struetural exposition of folic acid, it
was postulated that biochemically £~aminobenxoic acid functioned primarily in
the synthesis of tne former compound* This would explain why a nutritional
folic acid deficiency (which cannot normally be produced in rats due to
bacterial synthesis of this vitamin in the rat's caecum) can be induced by the
oral administration of sulfonamides* These drugs inhibit the bacterial
synthesis of folic acid from soic acid to the extent that the usual
physiological manifestations of a folic acid deficiency appear* Usually the
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effect of the sulfonamide antagonism of enteric bacteria can he revered by
folic acid (144, 145). Folic acid has boon reported to he clinically active
in the treatment of certain anemias of an aplastic character some of which
may have arisen following the us© of sulfa drugs (146, 149, 148).
acid* This is a non-essential amino acid* Glycogenic, it
yields o-ketoglutaric acid on. deamination* Substitution of acid
for the |f»fors in folic add yields an inaclve compound. (149).
.Derivatives of folic scti* k crystalline conjugate of folic acid,
pterqylhevaglutanylglutartlc acid, wen isolated fro® yeast (150)* This compound
was active for the chick, but only 2 to 5 percent as active uicro-biologieslly
as folic acid. It has since been shown that this is heptaglutamate, the fora
of trte vitamin predsminsnlly present in the vegetable kingdom (151)* In the
animal, free folic acid is a ops re- ily released from the conjugate through a
specific ensyfue action (152).
Pteroyltriglutamic acid ("fermentation Lactobacillus caqal factor") was
isolated in crystalline form (153), and shows to be active for Lactobacillus
easel and animals but only slightly active for Ltrcptococcua fat?cel is R*
Another naturally occurring member of this family which has been isolated
is ?* pteroic sold (rhieopterln) (154), which is active for streptococcus
4
feecalls H, but inactive for Lactobacillus easel and animals (155, 156, 35)•
Though folic acid is the most widely and efficiently used member of this
family of com mmds, there is a general feeling that it does not represent the
biologically active form* Because of this, numerous attempts have been made
to alter it in an effort to obtain a sore active compound* The presence of the
conjugate enzyme in animal tisanes and the isolation of the naturally occurring
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tri- and heptaglutsmatea have led to the investigation of various synthetically
produced expounds in which the number and linkage of glutamic acid molecules
have been varied*
Such synthetically produce,! members includes (a) pterole acid, active
for streptococcus faecalla ft, inactive for animals and Lactobacillus c&sei
(159), (b) pteroyl-Y-glutaaylglutamic acid, active for hactooaoillug oasei
and Streptococcus faecalis E (153), (c) ptemyl-a-glutamylglut,ante acid,
inactive for Lactobacillus casei and Streptococcus faecells R, but reported
active for mm (159, 160), aid (d) formylfolic acid, active la man (35) and
microbiologlcally (161)*
ifnrlfloa., arrtoHgtnw. aud m»ir derlrat-lvaa. In addition, certain
compounds, related functionally rather than chemically to the erythrocyte
maturation factor and folic acid, must be considered* Thymine was demonstrated
by Spies (162) to relieve the anemia in pernicious anemia, although there was
a continued progression of the glossitis and stomatitis symptoms which usually
accompany the reduced blood count*
Other purines and pyrimidines haw bmn teated and found to he clinically
inactive* The effect of nucleic acids remains controversial! hematopoietic
response has boon attributed to a mixture of nucleic acids (163), but Strauss
and Castle reported nucleic acids to be inactive even after incubating with
gastric juice (91)* k mixture of nucleotides is usually administered in cases
of agranulocytosis, a deficiency of a certain type of white blood cells*
There is some evidence that the adenine content is responsible for the thera-
peutic effect (164)*
The functional relationship between folic acid and purines and pyrimidines
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was first shown in micro-organisms. The folic acid requirements of three
species of Lactobacilli were found to he adequately taken care of by adenine
and other purines, guanine and xanthine could replace the adenine
(but were not as active); however other pyrimidines could not be substituted
for thymine (165). afaen Lactobacillus easel is inhibited by aothylfolic acid
it is found that the r»re sense of adenine, marine, hypoxanihine or xanthine
reduces to one third the amount of folic acid needed to overcome a given amount
of its antagonist. .Alone, thymine had no effect, but in the oresenes of the
purines, thymine reduced the critical amount of the acid still further - to
one tenth that required when both purines and thymine were omitted from the
mediun (166). Thymine has likewise been found to substitute for jj-minobanasoic
acid (167).
The desojjyrlbosides of purines and pyrimidines can be substituted for
the vitamin requirements of severs! micro-organisms (168, 169* 170).
Summation and Hypotheses
Generalised scheme to indicate possible rein tionghips between the
recognised macrocytic snaalaa* At the tin*# our investigation was initiated
in 194? a reasonable hypothesis could have been formulated in which the ultimate
cause of all the macrocytic enemies could have been attributed to a common
cause* namely a specific erythrocyte maturation factor# This difficulty could
evolve through a number of pathways and account for the variety of etiological
origins of macrocytic anemias* Thus one could visualise a general pattern with
interfering factors which might be represented as follows?
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Pellagra ( Pernicious anemia
Tropical macrocytic \ Stomach, carcinoma
anemia Extrinsic Intrinsic \ Gastrectomy
Nutritional macrocytic factor factor Pregnancy (?)
anemia 1
Pregnancy (?) J I
Snail Intestine
Intermediate product (?) \ Pish ta.-ewom infestation
Enteric incubation ■< Intestinal anastomoses





Erythrocyte maturation factor jLiver disease
i
gone Marrow
Normal hematopoiesis j Achrestic anemia
In view of the above scheme, it would be reasonable to expect the erythrocyte *
maturation factor to relieve all the macrocytic anemias with the exception of
achrestic anemia* That the explanation, however,, is not so simple became ap-
parent as the liver extracts used therapeutically became more and mor* refined#
Later, the clinical trial of folic acid, demonstrating Its marked hematopoietic
effect among toe macrocytic anemias, opened new speculation (29, 30, 31)*
the inadequacy of the scheme just presented can be accounted for in one
of ways* Either (a) there is no single basis for the evolution of the
macrocytic anemias, or (b) an Interrelationship exists between these anemias
which st the or*?sent is not apparent# As to which alternative applies cannot be
established yet due to our limited knowledge of how and where the various sub-
stances which are therapeutically active exert their effect#
Non-Identity of folic acid, and tm erythrocyte maturation factor* That
folic acid was not the erythrocyte maturation factor of lit r was realised even
before clinical trials wore made, for highly active liver fractions could be
32
shown to be essentially free of folic acid (only 0.25-0.5 micrograms per unit
of anti-pernicious anemia activity)(l7l). The amount of folic acid required to
relieve the anemia, though varying with the individual, was actually much
greater than the amounts of crude concentrates of erythrocyte maturation factor
required. The difference in efficacy is eves sore apparent now that crystalline
has been obtained. Whereas 20 mg. per day of folic acid is recommended
(30), 1 ?slcrogram mr lay of appears adequate (I^2).
The factors differentisting the hematopoietic effects of folic acid and
vitamin ares (a) the amount required to relieve the anemias (as just men-
tioned, there is more than s ten thousand fold difference between their ther-
apeutic doses)| (b) the much mors universal hematopoietic affect exerted by
folic acid 'than by the erythrocyte maturation factor (thus, no cases have bees
demonstrated of folic acid as bei g .ineffective where liver extract would
relieve the anemia, but conversely', macrocytic anemias arc sow recognised which
respond to folic acid but not to folic acid-free liver extracts) (l 7 3, 174* 17$).
In the combined system syndrom® of pernicious anemia, folic acid
affectively relieves the hematological eyeptoms, but fails to halt either the
development or progression of neurological symptoms. Some individuals even
dal"* that the administration of folic acid may accelerate the development of
neurological symptoms (176).
The inability of 819B19 to substitute for folio acid in nutritional or
inhibitor induced deficiencies has boon mentioned (p. )• Folic acid deficiency
seems to strike primarily at the myeloid (bone marrow) tissue, resulting in
an absolute cytopcnls* This relation lias fortes the basis for the use of
inhibitory folic acid analogues in myeloid leukemias* Similarly, folic acid
is used therapeutically to combat the leucoptnia due ’to irradiation or other
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myeloid tissue depressants (177, 146, 147). Such information suggests that
the hematopoietic activity of folic acid in myeloid tissues is more directly
concerned with tne blood forming function and that the role of vitamin
may be secondary.
The available data, in general, can be divided into two main categories t
(a) those primarily concerned with the extrinsic, intrinsic, and erythrocyte
maturation factor sequence, and (b) those in which there is an effort to
correlate the activity of the various therapeutically effective agents with
the physiological and biochemical deviations associated with the macrocytic
anemias which they alleviate in order to Indicate the function of these
factors in cell metabolism?.
Relations of various substances active therepeutieally to the extrinsic,
intrinsic, and erythrocyte maturation sequence, on-identity of folic acid and
the extrinsic factor. The possibility that folic acid might be the dietary
"extrinsic factor" was early postulated. A mass action affect could be pro-
posed to account for its activity in pernicious anomie (and the high level
required) since Goldrumor (17$) had demonstrated the presence, although in a
f.rert!y diminished amount, of intrinsic factor among pernicious anemia patients.
However, incubation with gastric juice failed to increase the hematopoietic
activity of folic acid (179). Later folic acid was found to be ineffective in
the prevention of the neurological symptoms resulting from the combined system
deficiency of pernicious anemia (1%, ISO). Folic acid was thus absolved of
the role of extrinsic factor.
Direct a-d indlrect impliestlong of the intrinsic factor in the
utilization of folic conjugates. After the isolation of folic acid conjugates,
34
there appeared reports concerning the inability of pernicious anemia patients to
use these compounds (i* e., no therapeutic response comparable to the one
ellicited by folic acid) (131, 182). lor ms there an increase in the amount
of free folio acid excreted, whereas normal individuals given folic conjugates
responded with an increase in the amount of free folic acid excreted. About
the same time, the presence of a conjugase (an enzyme which releases free
folic acid from its glutamic conjugates) inhibitor was reported to be present
in natural materials containing conjugates (183)* The inability of the anemic
patients to utilize folic acid conjugates could logically be due to a lack of
this conjugase, or to an Inability to cope with a conjugas© inhibitor.
The type of the reaction catalyzed by the conjugate enzyme shows it to
be of a proteolytic character* Since the literature contains several reports
postulating a proteolytic activity for the intrinsic factor, the trial of
gastric juice as a eonjugase was logical. No indication of conjugate activity,
however, was obtained.
The intrinsic factor could also be implicated as participating in
another way in the utilizetion of the conjugate* Thus the possibility existed
that its role was not a direct action upon the extrinsic factor, but rather
an inactivation of a conjugate inhibitor, allowing normal digestion and
utilization of the conjugate* Consideration of Jacobson*s work seemed to fit
in with such a scheme* Ha demonstrated that argentaffin* cells contain
granules, apparently composed of xanthopterin* Since these cells wore shown
to atrophy in pernicious anemia, they were believed to be a source of the
intrinsic factor (IQ7)* The folic acid content of liver homogenates vaa in-
creased upon incubation with xanthopterin (l*7!, 135)* From thea* observations
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it could be postulated that the intrinsic factor is xanthopterin or a de-
rivative thereof secreted by argentsffine cells and that the substanes
excreted functions by countering the effect of a conjugate inhibitor present
in natural substances*
Now, however, all the recent evidence indicates that there is utilization
of the conjugates by pernicious anemia patients (184)* It has also been de-
monstrated that although the conjugate inhibitor is active in vivo* its
effect In the normal and the anemic patient is the same (185)*
bruyze and Engel (186, 187) claim to have detected a change in the
nature of the folic acid conjugates following incubation with gastric juice
at pH 2*o* The exact nature of the change is unknown; it is detected by the
failure of oonjugase preparations to release free folic acid when It is
allowed to act upon the altered compound* Since it Is known that (a) the
inhibitory effect which glutamic sold has upon conjugsse activity, and (b)
that nepain, present in gastric juice, is active at pH 2»0, but inactivated
by a pH of 7.0, one might postulate that the alteration may be only the
freeing of 1 or 2 molecules of glutaadc acid* The compound so formed would
not of itself bo refractory to conjugate, rather there would be an inhibition
of the conjugate system by the freed glutamic sold*
The relation between the erythrocyte sm lteration factor end the
metabolism of folic acid* The influence of vitamin upon folic acid
metabolism or the utilization of stored folic acid remains problematical* It
has been reported that initiation of liver extract therapy in sprue causes
a large increase in the amount of free folic acid excreted, though no similar
occurrence has been noted in pernicious anemia (18i, 189)*
36
It has also been reported that livor extract appears to increase the
ability of pernicious anemia patients to fora free folic acid from its con-
jugates. This beneficial effect upon folic acid liberation appeared even when
the liver extract was tested in vitro with bon© marrow suspensions (190).
Recently If specifically has been Implicated in the formation of the conjugase
enzyme (191). Thus chick livers from day old progeny of depleted hens
show very slight conjugate activity. If, however, the liver homogenate is
incubated with. m increased conjugate activity develops.
MmaMs Gm?%rMlQn of fgiiS &SM JfeSt fi &228 MliiS
activity# There has been much conjecture ss to the possibility of enzymatic
activation of folic acid. Jacobson and Good (192) treated folic acid samples
with a xanthine oxidase preparation (from liver), and claimed on the basis of
clinical trials to have obtained a product with greatly increase:! activity,
so further reports of such an activation appeared until Morris published the
results of a aeries of experiments concerning the hematopoietic activity
(in vitro) of a substance, designated vitamin 3^ ; , isolated from urine (193).
The ohmic®! nature of this substance was not Indicated, but in the same series
of publications xanthopterin end folic acid, following incubation with xanthine
oxidase, were reported to exert a similar hotttopoietie effect. The inference
is that vitamin is a pterin compound, possibly folic acid, which has been
activated by the oxidase enzyme. Xanthine oxidase activity was also reported to
exist in the mucosa of rat stomachs. On this basis it was postulated that there
is no one substance existing as the extrinsic factor, but rather a series of
pterin compounds. In tula scheme, xanthine oxidase would be tne intrinsic factor
Since the xanthine oxidase properstians used in the above experiments con-
sisted of ends homogenates of gastric tissue, it is probable that they contained
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both easy** and substrate* There has been no demonstration that xanthine
oxidase is aeoreted or i® other than one of the system of enxymes occurring
in mucosal cell for trie same reason that it exists in many oth r tyoea of
tissues* The basis for assuming the intrinsic factor to 'be xanthine oxidase
is, therefore, subject to doubt* Further, it has previously been demonstrated
that the activity of folic acid is not increased following incub lion with
gastric juice (179)*
This question also arises* is there an enzyme, xanthopterin oxidase,
distinct from the xsnthine oxidase enzyme? From Kalckar'c work, it appears
that a separate xanthopterin oxidase ensyme exists, lie first reported an
inhibitory of act by folic acid noon its action (194), but later demonstrated
that 6»pteridylaldehyde, an irradiation breakdown product of folic acid, was
the inhibiting agent (195)*
Karris and Krebs state that there is no pterin oxidase, bat tost the
xanthine oxidase enayme acts upon xanthopterin (196). Enaction rate studies
indicate that xanthine is the true substrate, art! that xanthopterin forms a
less dissociable complex with the enzyme, and thus in effect will actually
exhibit an inhibitory action upon the oxidation of xanthine*
Xelaviona of fch£ substances t ierapeuticdiy active in macrocytic
Is he eM adbsgsSJLgai tMagtaai aLsa £s& emslm
yuan untrea ted* iX - s '.a choiieaatersse activity* The reduced red blood ©all and
plasm ©hoiineaterase level found in pernicious anemia ‘ms m-m mentioned*
lifter remission, the esterase activity values return to normal* Davis (197),
using dogs, vsa able to produce a macrocytic anemia by the admiaistr* tloa of
choline chloride or aoetylcaoline bromide* This, together with the above in-
formation led his to hypothesise that the mechanism responsible for relapse
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In pernicious semis was the increased acetylcholine concentration in the
blood stream resulting from decreased cholinesterase activity.
Administration of diisopropyl fluo.ro•.hoapha te (DFP) suppresses ceil end
serum ci.rolineatera.se activity. Through repeated injections of this suppressant,
low red blood cell and plasms cholinesterase activities have been maintained
in man (193), and animals (199). Ho changes appeared in hepatic, renal or
hematological functions. It was possible also by administering dilB®propyl
flunrophosphate to pernicious anemia patients to retain the reduced cell and
plasma cholinestoreso activity, even though complete remissions ware induced
with liver extract end folic acid truer®py (200). These experiments make Oavis 1
hypothesis untenable.
Incubation of folic sold with serum of low cholinesterase activity has
been reported to result in an increased esterase content (19?)• Similarly
the adisinistrstdon of folic scii to a normal individual causes the ssrm
cholinestaram activity to increase, k direct effect of folic acid epos the
rnzym® is thus indicated. Since liver extracts (containing no folic acid)
administration in pernicious anemia cases results in the sma (Zjl) chdili-
ester*se activity increase ss is produced by folic acid, these questions are
ralaad ' W doBa 8 12““
lneraa*a 1,8 *ia ChallnaaU”,a “
content of normal individuals, and. (h) does isesfeeiioa of vitaatn g-^
esterase deficient serial result in an Increased esterase activity? That is,
does vitamin also appear to affect this easyme system directly, or is its
action an indirect one, that of making folic acid available?
One would expect a similar low serum astermm activity in the other types
of macrocytic anemia, particularly those in which folic acid appears to function
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specifically, km yet few such studies have been made &;;d there la an insuf-
ficiency of data to draw any conclusions concerning this possibility*
Serum cholesterol lowering* The lowering of serum cholesterol should
be kept In mind because of its possible connection with the altered fat
metabolism and the development of the neurological lesions of pernicious anemia
The presence of & so-called acetate-replacing factor in liver has baas re-
ported This fact, coupled with the fact that acetate plays an important
role in cholesterol synthesis, suggest© a possible relationship of this factor
to the pernicious anemia syndrome which should not be overlooked* Heaterstics
of normal cholesterol value® follows remission induced by liver extract therapy
Beeauae of the inadequacy of folic acid in preventing the progression of neuro-
logical symptoms, it would be of interest to know whether folic acid has any
effect on the aenm cholaatcrol level.
Tyrosine metabolism* kn increase in the excretion of phenolic compounds
similar to that occurring in pernicious scents takes place in the scorbutic
guinea pig (203). In the former esse, remission of the anemia is accompanied
by a decrease in tbs axeratie* of phenolic compounds* This led to the observ-
ation that administration of folic acid (304) or folic acid-free liver extracts
(205) accomplished a reduction in the amount of phendle compounds excreted
by the guinea pig comparable to that occurring after the administration of
ascorbic acid*
Tmre is thus a question as to whether or sot ascorbic acid fees a direct
function is oemioiou* anemia etiology* The mean plasma level of ascorbic acid
was found to be decreased Is a series of pernicious anemia esses despite the
istake of diets containing adequate amounts of the vitasin (2D&). However,
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this low-red pLaoius level of ascorbic acid was found to be independent of the
extent of the anemia arid appears rather to be a .function of the degree of
achlorhydria. On the other hand, it was observed during World «ar II when
there was a widespread vitamin C deficiency among the English people that
the number of mmn of pernicious anemia failing to respond to liver extract
therapy was rising. Following, the dally administration of vitamin C, however,
those cases responded in a typical Banner to liver extract (207).
hactobacillus lactic Corner ATCC 8000, (318), Lactobacillus
ktCC 4*79*7 (169), and Lactobacillus leicrseannii ATCC 313 (160) require the
erythrocyte maturation factor for growth. It was found, however, that this
requirement could be entirely replaced by the addition of ascorbic acid to
the melius (209). bather the affect of ascorbic acid is a specific one or is
merely an agent affecting; the redox potential remains to be decided. Sodium
thioglycollate can tm vised to low r the redox potential, and does produce a
growth response in these microbiological testa, but the effect is not as sat-
isfactory as that produced by the ascorbic add.
t arr-ayrin aetsboliam. That pmrrhyrln s&et&boliem is altered during per-
nicious anamia. is apparent. Just where and why the alteration takes place
remain unknown. Following folic add therapy in pernicious anemia patients
a rod porphyrin-like pigment was excreted within four hours after tne adnla-
istr*- tion of the compound. so similar effect was noted following folic acid
administration to normal individuals (21.0). Hicrobidogleally, folic acid was
found to exert an effect on the porphyrin production of Corynohacterturn
h&t'P.mnxiiim Potassium cyanide diminishes por Pyrin production, md also causes
e slight decrease in growth (but the txsrpbyrin production was measured In cultures
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of the same optical density to prevent any effect due to an unequal amount
of growth). The addition of folic acid to the culture counteracted the
inhibitory effect of cyanide. In culture medium to which no cyanide had teen
added, the addition of folic acid caused an acceleration of growth (211).
More direct evidence concerning the effect of folic acid on porphyrin
metabolism tes bees obtained using weanling rats rained on & folic acid de-
ficient diet. The addition of folic acid to the diet resulted in an increased
fecal porphyrin excretion, but no alteration in the growth rate, however, when
3 percent sodium beasoste was added to the rats* diet, it caused a decreese
in porphyrin excretion, a decreased weekly weight gain, and u reduction in
the number of white blood cells. Then when folic acid ma added along with
the sodium benzoate, the porphyrin excretion, growth rate, and the whit© blood
count inerosaod again. Glycine (2 percent) added in place of folic acid
yielded similar results except that the white blood count remained low (212).
Glycine has been shown to act as a detoxifying agent for sodium benzoate.
Also its utilisation in por hyrin synthesis .i ias been demonstrated. Thus the
results of the above experiment can best be interpreted by assuming that folic
acid is Involved in the cellular production of glycine.
Biosynthesis and uvilisati m of purines and mrtaldlnea* Through the use
of microbiological techniques a relationship has been detected between the bio-
synthesis and utilisation of purines and pyrimidines and the functions of folio
acid and the erythropy ta .maturation fastor.
Thymine or thymidine can be substituted for folio acid when growing
streptococcus faecalia &• To obtain maximal growth with either folic acid or
thymine it was necessary to add adenine to the culture medium* Three otter
Species of folic acid requiring Lactobacilli were tested and shown to have the
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same alternative requirements (163)*
Competitive analogue-metabolite growth inhibition using methylfolic
acid showed that folic acid functions in the synthesis of purines, pyrimidines
or their equivalent (166).
What ftreat relationship exists between £-amlnobaxizolc acid and folic
acid and between these two vitamins and the purines and pyrimidines is not
definitely known* From studies using competitive &aeloue-metabolite growth
inhibition, it appears that folic acid is a product of j>-ami.nobenaoic acid
metabolism. Cto the basis of tn© antibacterial index changes the following is
proposed as the order in which the synthesis of essential factors became
limited (213) l (a) methionine, (b) purines and pyrimidines, (e) serine,
(d) folic acid and (e) unknown substances related to amino acids* The order
of folic acid and serine may be reversed * The question arises* does ja-amino-
henxoic acid function in the synthesis of purines and pyrimidines apart frost
its role in folic acid production?
When Escherichia coll are grown under conditions of swlfa inhibition
for which purines and pyrimidines are the limiting factors for growth, an
amine, 5(4)-amino-4(5)-imidazolecarboxamide, is found to accumulate in the
culture medium (214)* By the addition of a single carbon unit to this amine
the purine ring structure is obtained* It would appear that a coenzyme function-
ing in the transfer of single carbon units has been blocked*
It has been indicated that there is a relationship between purines and
vitamin was 3Ubpli©d to Lactobacillus lactis Lorner* purities
were found to be non-essential although they are capable of exerting a sparing
effect on the vitamin requirement* Lactobacillus leichnrannli ATCC 4797,
which can also be used to assay for vitamin was found to also require
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folic acid* Thymine after a lag phase was able to replace the folic acid (215)*
Experiments with animals have indicated that dietary guanine and cytosine
are not incorporated into the nucleic acids, though apparently adenine may be
so utilized (216, 217). An inability to utilize purines and pyrimidines as
effectively as the nucleosides in nucleic acid synthesis has been noted for
a strain of Senroapora (218)* The purine and pyrimidines requirements of many
micro-organisms, however, indicates their ability to incorporate the preformed
molecules into nucleic acids*
The replacement of the vitamin requirement for micro-organisms by
desoxyribosides has been reported (163, 169, 170)* Clinical trials of the
desoxyribosides in pernicious anemia, however, have apparently not been success-
ful* The amount given or the method of administration may, however, have been
unsuitable* At present the difficulty entailed in obtaining pur® material
seems to have prevented the completion of an adequate investigation* Until such
an Investigation is completed, no definite statement can be made concerning the
effectiveness of desoxyriboside® in pernicious anemia*
The nutritional replacement of folic acid by thymine, and of vitamin
by desoxyriboside in micro-organisms suggests an interesting clinical re-
lationship that might exist* Since folic acid or thymine will cause s hemato-
poietic response in pernicious anemia, and whereas * s effective both
hematologieally and neurologically, it would be interesting to know if deeoxy-
ribesides are completely ineffective, or whether they might not cause a neuro-
logical response#
An impairment in the synthesis of desoxyribonucleic acids, but not of
ribonucleic acids was shown to result when Lactobacillus easel was grown in
a medium deficient in folic acli (219)• To eliminate the possibility that
44
this effect on desoxyribonucleic acid synthesis was due to a specific vitamin
deficiency, and not something which might result as a lack of any one of the
nutritionally required B vitamins, a similar series of tests were carried
out using media deficient in riboflavin or biotin. In these cases the only
noticeable change was a moderate increase in the -synthesis of both types of
nucleic acids. Supplementstion of the folic deficient Lactobacillus easel
medium with an excess of thymine also resulted in an increase in both types.
The effect of folic acid in nucleic acid synthesis is also indicated
in experiments on the sulfonamide inhibition of the psltacossis virus ( a
nucleoprotein)(22o)• Folic acid was found to effect a non-competitive reversal
but jg-siainobenxoic acid or pteroie acid ware found to be competitive revers-
ing agents. Glutamic acid had no effect upon the sulfonamide inhibition.
.g-Aralnobenzoic acid has been found to have an inhibitory effect on the
development of Rocky Nountain and related ricketsial fever® (221, 222). A
similar chemotherapeutic effect has been noted for jg-aainobenaoic acid in
typhus and murine typhus (223, 224). In view of the sulfonamide inhibition
experiments upon the psi tacossis virus it is difficult to deduce a possible
explanation for this action of p-aainobenzoic acid unless it is acting as an





Before the experimental information which was summarised in the pre-
ceding section can be logically explained, a number of questions must be
answered. Our interest lay in exploring for leads which might aid in
answering these fundamental questions.
1. What is the nature of the intrinsic factor?
2* What is the nature of the extrinsic factor?
3# What is the character of the reaction which occurs when the
intrinsic and the extrinsic factors interact and where does
this take place?
4* Does the erythrocyte maturation factor present In the liver
develop
a* as the direct result of a reaction between the intrinsic
and the extrinsic factors which yields the erythrocyte
maturation factor?
b* fro® an initial elaboration of an intermediate product
(the product of an intrinsic-extrinsic reaction) which
is subsequently converted to the erythrocyte maturation
factor?
Gm due to a more indirect action of the intrinsic factor
(e. g., by facilitating absorption of the extrinsic factor,
or perhaps by protecting the extrinsic factor from de-
struction in the stomach or small intestine)?
5* What is the function of the erythrocyte maturation factor?
The hypotheses that were proposed and tested are reported in this section.
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A.
DISTRIBUTION OF FOLIC ACID ACTIVITY VS.
THE MORPHOLOGICAL STRUCTURE OF INTESTINAL MUCOSA
The first hypothesis to be tested was one concerning folic acid and a
particular type of cells occurring in the gastro-intestinsl tract, the
argentaffin© cells. Folic acid in large doses had been shown to produce &
hematopoietic response in pernicious anemia patloots (but at that time had
not yet been shown to be inadequate in the treatment of the neutral conditions)
Jacobson, in 1939 while making a (225, 107) study of the argentaffin® cells,
noted the presence within these ceils of granules having properties of pterins,
and later, on the basis of absorption studies (226), suggested they were
xanthopterin. There was a marked diainishmsnt or complete absence of these
cells in toe alimentary tract of individuals who had had pernicious anemia,
when they were compared to speciments obtained from other autopsy cases.
Since it had been established that pernicious anemia results from the loss of
a secretory capacity, a possible relation of these cells to the secretory
function was indicated. Hence it was postulated that these cells could bo?
a* the source of the intrinsic factor,
b* the site of localisation of the intrinsic-extrinsic reaction
product following its absorption, or
e. the source of a third or intestinal factor, whose production is
somewhat dependent upon the intrinsic factor*
The nan-identity of folic acid and the extrinsic factor had been
established, but, since there had been demonstrated a functional relationship
between these two factors, it seemed propitious to investigate whether the
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pterin-like granules of the argontaffine cells might not in reality be com-
posed of folic acid or some functional derivative.
Fresh hog duodenum was obtained from the local abattoir and separated
by the method described by Jacobson Into three fractions having the com-
position indicated:
a* a fraction almost entirely constituted of villi and the crypts of
Lieberkuhn but containing the argentaffin© o@!i%
b. a fraction predominantly Prurmer glands, and
c. the duodonal Roseola tore
Each .fraction was assayed for its folic acid content microblologieally *
The extracts were prepared by tree ting the tissues described in the general
method for the enzymatic liberation of E-vitamins (22?). Extracts were also
prepared by using an enzyme concentrate (prepared fra® hog kidney)(lsl) which
contained vitamin B
c
conjugate, the enzyme which hydrolyzes the palyglutamyl
derivatives of folic acid. Both types of preparations were assayed in both
the Streptococcus faeoalls E and Lactobacillus cssel £ methods (228, 229)•
ho significant differences in the folic acid activity® of the
three layers could be demonstrated.
Subsequently Wilkinson (230) showed that only the first fraction from
such a reparation possesses clinical activity when used in the oral therapeutic
treatment of pernicious anemia.
Our results indicated that there was no extensive localisation of folic
acid in the therapeutically active layer and they did not offer any sub-
stantiation to the possibility of the pterin-like granules 1 being folic acid*
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TABLE 1
FOLIC ACID COMTE!? OF ffiJGDLM&L FRACTIOUS
(aicrograms per gm. moist tissue)
Lactobacillus easel k&sm
Mo Conjugate Conjugate*
Fraction a* 0.3 0.3
Fraction fe. 0.5? 0.85
Fraction e« 0.24 0.35
Straotoeooaua faeealis E Assay
I© Conjugate Conjugsso
Fraction a* 0.45 0.8
Fraction b* 0.^5 1.35
Fraction e. 0.45 0.8
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B.
THE EFFECT OF THE INTRINSIC FACTOR UPON THE INHIBITORS
OF FOLIC ACID CONJUGASE
When it mu found that pernicious anemia patients, unlike normal subjects,
could not utilise folic acid conjugates (181, 182), the intrinsic factor was
tested for its activity as a conjugate ensygie* It was found to have no direct
action upon folic sold, conjugates* However, since conjugas© inhibitors had
been demonstrated to he present in natural materials containing folic acid
i 1
conjugates (183), we attempted to show that the intrinsic factor might have
an indirect action on the utilisation of folic acid conjugates, that is, that
the intrinsic factor sets a s a counter-inhibitor end in some way prevents the
action of the naturally occurring Inhibitors. Accordingly, yeast extracts
(which had been shown to contain both folic acid conjugates and the oonjugase
inhibitor) were incubated with a conjugate preparation in the presence and
absence of gastric juice* It was proposed that if the intrinsic factor exerted
its action by counteracting tbs conjugate Inhibitor, an increased amount of
free folic acid should be liberated from the samples to which Intrinsic factor
(neutralised gastric juice from a normal subject) had been added* Micro-
biological assays for folic acid activity using both Streptococcus faec&lla H
I ff
(228) and Lactobacillus easel (229) ware carried out on the various Incubation
samples, but no effect of the added gastric juice could be detected* This
postulated mechanism was therefore discarded*
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TABLE II
The presence of xanthopterin has boon shown to increase the yield of
free folio acid when liver homogenates arm incubated. This is not the result
of its conversion to folic acid as was first thought but is probably the result
of its ability to inhibit an ©nsyme system which destroys folic acid (136)*
It is conceivable that xanthopterin might likewise interfere with the naturally
occurring inhibitors which limit the activity of the liver conjugaee. Similarly»
one could postulate such s function for the argentaffin© cells when they produce
xanthopterin or a xanthopterin derivative* Hence, xanthopterin was used in a
series of tests similar to those described in the preceding paragraph but it
was found to have no appreciable effect on reactivating the inhibited conjugate
system*
FOLIC ACID L IBMAT IDS FROM ITS CONJUGATES
(aicrograms per gat. yeast extract)
Folic Acid Content >
Incubation Mixture Assay Organ!an
Lactobacillus i'troptococcu
easel Siasalia *
Yeast Extract (dry weight) 0.9 1.1
Conjugate preparation (0*05 ce.) 0.0 0.0
Heutral gastric juice (0*1 ce*) 0.0 0.0
least Extract ♦ Conjugate preparation
(0*1 mg - 0.1 ce.) 17.8 4.9
Yeast Extract * neutral gastric juice
(0.1 mg - 0*2 ce*) 0.9 1.1
Yeast Extract ♦ neutral gastric juice
♦ Conjugate preparation




THE RELATIONSHIP OF XANTHINE OXIDASE TO THE INTRINSIC FACTOR
There are several indications that folic acid is not the form of the
vitamin, which is eventually utilized! thus, there is an extreme discrepancy
between the dietary intake and excretion of folic acid especially when a coiit-
parison is made with the other B-vi taming, and there are a large number of
derivatives which have been found to occur naturally which havemrylug
letlvitUi dmpmmdimg « m Warn tost >rganlmi aail« Immw «f ttia thgrm hsv#
been a number of attempts to produce a more active form of folic acid.
Jacobson and Good (211) reported that by the incubation of folic acid with
a xanthine oxidase preparation (from liver), they obtained a product possessing
THE EFFECT OF XANYHOPT-JIXN UPON
THE LIBERATION OF FOLIC ACID FffiM ITS CONJUGATES
Incubation Mixture Assay Organism
rstraptococcua
faeealis H
Yeast Extract (dry weight) 0.45
Xanthopterin (10 y) -
Conjugsse (0*05 cc.) -
least Extract ♦ Conjugate preparation
(0.1 mg - 0*1 cc*)
3.3
Yeast Extract ♦ Xanthopterin
(0.1 mg - 100 y)
0.4
least Extract ♦ Xanthopterin
♦ Conjugate preparation
(O.X mg - 100 y * 0*1 cc.)
2.4
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a hematological activity greater than could be accounted for on the basis of
its folic acid content* This report ushered in s series of experiments con-
cerned with the action of xanthine oxidase upon folic acid. The work of
lalckar and Klenov (232) indicated that there was an enzyme, xanthopterin
oxidase, distinct from xanthine oxidase, but as yet there does not see® to
fee any clear cut evidence as to whether or not this is a separate enzyme
rather than just another manifestation of a non specific xanthine oxidase-
like activity. The term xanthine oxidase will be used to designate the pre-
paration which was used in the work reported below and which catalyzed the
oxidation of both the substrates (xanthine and xanthopterin).
At first It was thought that folic acid inhibited the activity of this
enzyme, but later it was shown that 6-ptoriiyl aldehyde, a breakdown product
of folic acid formed upon illumination, was the true inhibiting agent. There
was no discernible difference in the ultra violet absorption spectra of folic
aeld after being treated with the enzyme, nor could any alteration in its
microbiological activity be detected (194)♦ Morris and Majnarich (131), how-
ever reported that the activity of folic acid when tested upon bone marrow
cultures Is very such increased after being treated with a xanthine oxidase
(milk) preparation* These investigators also used gastric mucosa and de-
monstrated it to possess the folic acid activating activity of their xanthine
oxidase prepareiions* From this observation they postulated the identity of
xanthine oxidase with the intrinsic factor. He were thus interested In making
a direct demonstration of the presence in gastric juice of xanthine oxidase*
Using the dechlorination of methylene blue in Thunberg tubes as our
criterion of oxidase activity, w© found that normal gastric juice showed no
oxidase activity for any of the substrates tested. Gastric mucosa slowly
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decolorized methylene blue even in the absence of added substrate, presumably
due to the presence of other dehydrogenating enzymes and their corresponding
substrates. We were unable to demonstrate any pterin oxidase activity in the
secretory products of gastric mucosa, furthermore, m were unable 'to obtain
any indication that folic acid could function as a substrate for an enzyme
preparation known to .possess xanthopterin oxidase activity.
The enzyme preparations that were used wares
a. xanthopterin oxidase prepared from raw milk by the method
of Kalckar and Klenov (232).
b. gastric juice from a normal subject (filtered and neutralised).
e. the supernatant fluid obtained by centrifuging an extract
made by hostogenaling mucosa scraped from the stomach of a rat
with ten volumes of 0.2 M phosphate buffer (pH 6.8).
the substrates that were used were 2
a. xanthopterin, 100 salerograms per ad. with enough sodium bicar-
bonate added, to affect solution of the wtarin.
fe. folic acid, ICX) micrograms per ad. of phosphate buffer, 0.2 M.,
pH 6.8.
One and a half ml. of the ladiestod enzyme sources were tipped* after temperature
equilibration at 3?°C., into a solution containing 2 ml. of the substrate and




STUDIES USING BONE MARROW CULTURES
Without an assay specific for the erythrocyte maturation factor it is
impossible to characterize either the reaction by which it is formed or to
locate the site of formation. At the time this investigation was undertaken
the only available assay method for this factor wes a clinical trial upon
pernicious anemia patients in relapse.
Th® inadequacies of this technique are very apparent. The investigator
is faced with what might be termed *huaan factors*1 a reticence to experiment
when a human life is involved} difficulty in obtaining subjects} individual
variation in response* usually overcome in animal experimentation by using a
statistical approach} and the possibility of false results due to a spontaneous
remission of the patient. In addition* there are the factors of time and
expense* both of which are great. The desirability of obtaining a simple*
concisive method of assay is obvious. Attempts to produce a syndrome in
ACTIVITY OF THE INTRINSIC FACTOR UPON FOLIC ACID
IN AN OXIDASE SYSTEM
Source Substrate
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animals similar to the pernicious anemia syndrome in man have consistently
failed.. Wherever positive results were indicated in such attempts, it was
always found that some other nutritional factors, in addition to the erythrocyte
maturation factor, would cause a remission of the induced anemla. The small
amount of data concerning the chemical nature of the erythrocyte maturation
factor precluded the development of a chemical test.
In vitro studies based upon the clinical findings have been attempted
with bon© marrow. It is possible to obtain a relatively good concentration
of reticulocytes fro® bone marrow by centrifugation as these cells have a
smaller density, than moat of the bone marrow elements, k report by May (233)
indicated that the maturation of retieolsyteg Incubated in vitro in a glucose-
free Tyrode 1 s solution could be of 'acted by the presence of the erythrocyte
maturation factor. We experimented in an attempt to utilise the method on a
quantitative basis. Uniform suspensions of reticulacyt© preparations con- •
centrated from rat bone marrow by centrifugation (233) were incubated in
glucose-free Tyrode * s solution at 37®C. for periods of four and six hours with
varying amounts of liver extract (£ll Lilly and Co., 10 U.3.P. units per ml.).
Smears were made before and after Incubation and the reticulocyte counts compared.
We were unable to show anything other than a qualitative indication that the
addition of liver extract caused an increase in the maturation of the reticulocytes
E.
DEVELOPMENT OF ASSAY METHODS
Sirica progress on studies attempting to interrelate the hematopoietic
agents was drastically limited by the non-existence of any practical assay
method for the erythrocyte maturation factor, it was decided that s search far
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a simple method for analyzing for the biological activity associated with
this factor would be a worthwhile project. Consequently, such a search was
undertaken.
The us© of microorganisms for assaying the various known components
of the 3-vitamin group has been extensively developed. It is now generally
believed that all of the B-vitamins are essential coll constituents of all
microorganisms as well as other types of cells, for each organism It is
possible, however, to place each of the vitamins into one of four categories:
vitamins which can be synthesised at an adequate rate by the
organism itself; ®esss»tisl* vitamins which must be supplied intact to the
organism; vitamins that can be synthesized when one or more parts of the vitamin
are supplied; and those vitamins that are synthesized so slowly that they can
become the factor limiting the rate of growth.
It aeeaed feasible, therefore, that it might be possible to obtain a
microbiological assay for the erythrocyte maturation factor if it were a
catalyst of general biological importance. It appeared likely that jg-aaino-
bansoic acid was fundamentally involved either is the utilisation, function,
or elaboration of the erythrocyte maturation factor, because (a) jg-aaiaobenzoic
acid is a part of the folic acid molecule and (b) folic acid is involved in
hematopoiesis, but is sot identical with tha erythrocyte maturation factor.
(It is uncertain whether jg-amlnobenzolc acid and folic acid function by being
incorporated into the same eoenzyme).
Since folic acid (also thymine) and tha erythrocyte Maturation factor can
to gome extent be interchanged in the treatment of the hmmaiologlcal symptoms
in pernicious anemia, it was decided to see if similar substitutions could be
made in the requirements of microorganisms. If such cases could be demonstrated
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then microbiologies! assays could be devised. Since it was not known whether
jg-amlnobenzoie acid functions solely in the synthesis of folic acid coenzyme(s)
or is in addition incorporated into other coenzymes, it was decided that a
-wider rang® of possibilities could fee encompassed by considering j>«aminobenzoic
acid functions rather than folic acid functions, two alternatives were con-
sidered* the complete replacement of the jg-aminobenzole acid requirement by
the addition to the media of sources of the erythrocyte maturation factor, and
supplements v ion suboptimum amounts of £*aminobenzoic acid with the erythrocyte
.maturation factor (i. e«, use the latter as a sparing agent)• In carrying out
these studies, it was of course necessary to test the influence of purines,
pyrimidines, folic acid, and individual amino acids (substances which had baen
shown to be functionally related to jg-aminofeenzoic acid)(2l3) sine® the nut-
ritional requirement for them might be replaced by utilization of the erythrocyte
maturation factor, or they conceivably could be functionally related by reason
of their being metabolites necessary for the functioning of the erythrocyte
maturation factor.
.Preliminary tests were made using three jj-amimebensoic acid-requiring
organisms! Lactobacillus arablnoaue. crsasa mutant, and A.cetobacter
auboxydana. Due to the difficulty experienced in obtaining growth of the last
organic in a well character!roc! media, it was soon dropped from the experi-
ments to be described*
From a study of the substitutions which coulci be made in the nutritional
components furnished these organise, it was possible to demonstrate a biological
response to severs! factors which are present in liver extracts used thera-
peutically but which could not be identified with known vitamins or growth factors
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factor replacing purines for Lactobacillus arablnogna, This organism
requires for growth, in addition to other substances, (a) a purine, (b) a
pyrimidine, and (e) jj-eminobenzoic acid. However, it was found that the
purine requirement can be replaced by some substance(a) present in liver
extracts which, on the basis of the small amounts of vary crude concentrates
required, must be active at a level very much lower than that at which the
purines must be supplied. The assay procedure developed for this factor is
summarized in Table VI and the typical response of the organism to It is re-
corded, In an investigation of sense of the chemical and physiological prop-
erties subsequently undertaken by my colleague, Mrs, Robert Lane, it was
shown that this factor(s) differed fro® the purines themselves not only in the
magnitude of the requirement but in a number of chemical and physical prop-
erties (234)*
Pyrimidine replacing factor for Lactobacillus arablnosmu In s similar
fashion it was shown that the pyrimidine requirements of this organism could
be met by something present in liver extracts, and an analogous assay method
was devised (see Table Til for procedure and characteristic response of the
organism)• this factor wss believe to be an entity distinct from the purine-
replacing factor because the substances active in the two tests did not behave
similarly when liver extracts were fractional by absorption on and elution
from charcoal and by partition between aqueous and organic solvents (234)•
two factors sparing the ja-aminobengoic acid, requirement of hauroapora
crassa* The jo-aminobenzoic acid requiring mutant of fenrospora crassa ap-
parently requires jg-aainobenzolc acid itself and it is impossible to replace
the vitamin by the amino acids, purines, and pyrimidines, whose syntheses it
catalyses, nor even by crude liver extracts* However, if subo .ytiraal amounts
of j»-aminobcmzoic acid, insufficient to promote appreciable growth (0.002
micrograms par 10 ml* culture) are supplied, then the mold responds to sub-
stances present in crude liver extracts.
Liver extracts (£ll Lilly arid Company) having potencies of 2,5, 10,
and 20 U. S* F« units per ml* were tested according to the procedure outlined
In fable VIII* These were diluted to contain equal unitags per cubic centi-
meter. When assayed, however, unequal responses were obtained} on a unit
basis, the 5, 10, and 20 unit extracts were less active than the less refined
2 unit preparations. Purines, pyrimidines, folic acid and hydrolyzed casein
were tested for their ability to replace the stimulatory material(s) in 2 unit
liver preparations. Their combined effect was not comparable to that obtained
with the 2 unit preparations* An electrolytic fractionation of the 2 unit
liver extract was carried out in a five cell unit (235). Upon recombination
of cups I and V, the most basic and the most acidic fractions, almost all the
original activity was recovered. However, when tested separately these
' in-
fractions showed only a fraction of the activity of the starting material*
The acidic fraction (that in cup V) was tried as a supplement to the 5,
10, and 20 unit preparation in assays* Increased growth response was indicated
but consistent results could not be obtained. Conversely, In the presence of
an addendum of the basic fraction, the response was a mas 3l,ire of the "acid factor*
Subsequently, whan highly refined concentrates of erythrotin (vltorain
and foiinic acid (a folic acid derivative required by Lsuconostoc cltrovorun) p
became available it was found that in the presence of the suboptimal amount
of p-amiaobenzoic acid, vitamin was relatively inactive} foiinic acid
concentrates gave some growth response} the combination of vitamin Bj? and
foiinic acid gave a better response, but one that was not equivalent to that




RESPONSE Of 4 i-&£Utm-WlQlC 4010 umuma
MUT&MT OF MPm-Q'■mm CiussA (atc. m.
Medites, testing conditions, etc. , those described in Table ¥1X1* (-
growth Response
Ln Arbitrary Visual Units
Ho jo-antino- 0.02 y ]>*a;T.ino-
bensoic acid benzoic acid
per 10 ml. cul lure






8 milliunita of 2 U.8.P.
unit liver extract ♦
8 milliunits of 10 U.S.P.
unit liver extract
8 ailliunits of 31 O.5.F.
unit liver extract -5 *
Activity of fractions separated
by electrical transport tooted
at a level equivalent to that
obtained from 8 Milliunits of
2 U.3*P* unit liver extract
per 10 ml. culture
Cup I (pH 10.3) *♦
Cap XI (pH 7.1) *
Cup XXI (pH 6.2) - -
Cup IV (pH 5.25) « -
Cup V (pH 3.0) • +
411 Gups *1
4* '









per 10 sl« culture
Activity of liver concentrates
in presence of acidic arid basic
factors separated by electrical
transport equivalent to 8 «illi«
units per culture
Acidic fraction supplement (Cup V)
Alone •» 4
Plus millivmits of 5 >!•$•?• )
unit liver extract «• ♦4- +■ /
Hus B nilXluBlts of 10 U *S.P« y r I*
unit liver extract
Flos B mllliunlts of 20 U.S.P*
(
\
unit liver extract 44-t-
Basie fraction supplement (Cup l)
Alone





Hus 3 uilliuniti of 10 U.S.P*
unit liver extract
Fins B aillitmlta of 20 tJ.S.P.
444
unit liver extract 444
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F.
EVALUATION OF ASSAY METHODS
Other members of the research groups of The Biochemical Institute bad
concurrently developed microbiological assays for unidentified factors present
in the liver preparations used in treating pernicious anemia patients. Four
of these assays were based unon the activity of the naturally occurring sub-
stances in reversing the toxicity of growth inhibitors structurally related
to j>~asi«ob«nzoie acid, folic acid, and a purine (guanine). Because these
factors were active in reversing such inhibitors, they were assumed to be
functionally related to jg-aminobenzoic acid and folic acid and hence might be
the erythrocyte saturation factor itself or a structurally related compound.
In the surveys described below these four assays were run simultaneously with
the three assays developed by the author. 41so included in the screening
program was the acetate replacing factor (2Q2) since certain liver preparations
were a rich source of this factor and since there is a functional relationship
of this factor to the metabolism of cholesterol and fatty acids, both or either
of which may be concerned in the neurological involvement in pernicious anemia.
Two approaches wore used in attempting to establish which, if any, of
these factors is the erythrocyte saturation facton first, a comparison was
made of the microbiological activities of e number of preparations having dif-
ferent anti-anemic (clinically) potencies and determining how closely the
relative clinical and microbiological potencies paralleled one another, k more
specific criterion for detecting a test which responded to the erythrocyte
saturation factor would fee the determination of the microbiological response
to the incubation procedures which rroduca clinical results. that is, from
the work of Castle and others described in. detail in the first section there
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is evidence for the formation of a heat labile compound intermediary in the
formation of the erythrocyte maturation factor* It is plausible that such
an Intermediate could be utilised in lieu of the erythrocyte maturation factor
by some organisms. Thus, if an enhanced activity could be demonstrated for
an incubation mixture of intrinsic and extrinsic factor preparations in one
of then© assays it would be indicative that the organism might require the
erythrocyte maturation factor or its precursor.
The preparations used in screening the various assay methods for
uncharsctarised factors were obtained in the following manner*
Extrinsic factors A piece of weighed, lean beef was chopped and
homogenized one half hour in a ‘waring blender with a measured amount of water.
To the homogenate was added enough 95 percent ethanol to yield solution having
an alcohol content of SO percent. This was allowed to stand with occasionally
stirring for four hours and than stored overnight in the refrigerator. The
mixture was filtered (with aid of FilteivCel) and evaporated on a steam bath
until it became very syrupy. This concentrate was extracted twice with benzene
and twice with ether. After the amount of solid material had been determined,
the preparation was diluted with water (50 mg. solids per ml.), the solution
tubed in five ml. aliquots, and the samples sterilized and stored in the
refrigerator.
Intrinsic factors Two sources were used 5 (a) undiluted gastric juice
(obtained by lavage of the author) which was immediately neutralised end stored
in the frozen state, (b) a dried preparation of hog intestinal mucosa (Hi
Lilly snd Company)*
Erythrocyte maturation factor* Commercial preparations (Eli Lilly and
Company) of liver extracts (Liver Injection 0. S. F.) of varying degrees of
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refinement indicated were used.
Incubation mixtures? One .ml, aliquots of the extrinsic preparations
ware incubated at Jfm C. for four hours with 1,5 ml* of neutralised gastric
juice, and the samples then diluted for assay. One ml. aliquot of water
plus 1.5 al. of the normal gastric juice were carried through the procedure
simultaneously and served as controls.
YabXss through XII matmarize the assay Methods and record the




Organism 5 Lactobacillus arabinosuo 17-5
Medium* Medina of Landy and Dicken (236j $ asparagine, folic acid and
purines omitted* 100 millimicrograrss jwsminobensoic acid and
100 milllad crograms folic acid added per tub®.
Tasting
procedures 16 hour incubation at 30° C. - 10 cc. cultures
ftddendxm Growth Response in
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Organisms Lactobacillus arahiaosus 17-5
Med liras Medium of Landy and Dicken (2%); asparagine, folic acid and
pyrimidines omitted. 100 millioierogrsms p-aminohsnxoic acid
and 0.1 micro rams folic acid per tube.
Testing
procedure; 16 hours incubation at 10* 0* * 10 cc. cultures
Addendum Growth Response in

































Addomhaa Growth iw&txmm in



















FACTOR STMJUTI IG THE GROWTH OF Q$4§^
(jg-aminobenzoic acid requiring autant)
Organ! mt Neuroapora crsssa ATC 9278.
Cultures inoculated with a dilute saline suspension of spores
scraped from agar stock cultures •
Mediums Ammoniua tartrate 5.0 g*
Ammonium nitrate 1.0 g.
Potasaiurn monobasic phosphate l.o g.
Magnesium sulfate 0*5 g.
Calcium chloride 0.1 g.
Sodiim chloride o.l g.
Sucrose 15.0 g.
Biotin 5.0 Y
Trace Elaments 1.0 ee.
Water to make 1 liter
Trace K1events?
Sodium tetraborate 88 og.
A&rooniun molybdate 64 mg.
Ferric chloride 500 mg.
Zinc sulfste heptohydrate 2 g.
Cupric chloride 270 ag.
Manganous ehlorlde 45 mg.
Water to make 1 liter
Medina for each 10 ml. culture supplemented with the acidic fraction separated
by electrolysis (Cup V, Table V) from 8 aiiliunits of Eli Lilly sad
Co. 2 U. S. P. unit liver preparations.
1l
testing Procedure| -24- uo*n: incubation at 30® 0* - 10 ee. salturea in
50 ec. Erlemseyer flasks, fic A cjl
i ,
Addendua Msmsa


























Organism! Lactobacillus arablnogus 17-5
Medinas Medium of Landy and Dickon (236); guanine omitted* 0*1 y ©-amis©
benssoic acid, 0.1 y folic acid , and 5 Y aaoguanine added per culture.
Tasting
procedure* IS hours incubation at 30* C* •- 10 ml. cultures.
Addenda growth Response in




























The test far this factor(3) developed by Dr. Beverly Guirard, is
based upon the counteraction of the inhibition resulting from the addition
to the medium of a structural analogue of guanine, (7-amino~l-v-triasolo-
(d)-pyrimidine, designated atagueoiM) • It is believed that the organism
responds in this modiiff? if either the guanine (or derivatives) required for
nucleic acid metabolism is supplied or if m factor(s) catalysing the
synthesis of this purine is present in catalytic amounts.
Addendum Growth Response in
Incubation mixture contain-










• *> * 1.0 H
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TABLE X
The assay method reported her© is essentially that used by Guirard, Snell
and Williams (202) when they demonstrated the natural occurrence of




Medium Mediisa of Laniy and Dicken (2%); sodium acetate emitted.
25 ogR« per culture.
Testing
procedures 18 hours incubation at 37w 0. - 10 ml. cultures.
Addendum growth Response in



























This test, developed by Dr, Winifred Harding and Or. William Shive,
measures the activity of factor(s) reversing the inhibition of a
structural analogue of folic acid. Subsequently Dr. Shive and his
covorkers, using this assay isolated fro® the 30 unit liver extract
the desoxyriboside, thymidine.
MSTHTLFGLIC BfflmgZM FACTOR*
Organisms Louconostoc masonturoides 8293
Mediumi Modiuss of Lundy end Diciten (236); folic acid omitted. 10 micro-
gratis of p-aminobenzoic acid, 30 micrograms of folic acid and
200 y methylfolic added per culture*
Testing
procedure! 18 hours incubation at 30® C. - 10 ml. cultures.
Addendua Qrwth Response la





























OrKaisl»m LsotobacUlua arsblnog-Js 1*7-5
Mediums Mcdiiss of Landy and Dickon (236) % folic acid omitted* 10 ®g.
of sulfonamide, 3 Y of p~sminbhensoic scid, and 3 y folic acid
added par cultures*
Testing
proceduret 18 hours incubation at 30® C. * 10 cc. cultures.
|ddendi«& Growth Response In



























This is one modification of several assay aethode employing inhibition
developed by Dr* William Shiv© and his t ssociateg in their search for
factors functionally related to and folic acids <2l3)*












That none of the tests employed were responding specifically to a pro-
duct formed by an extrinsic-intrinsic factor reaction was evident from the
results of the screening program for which typical data were reported. How-
ever, the results of the comparison of the microbiological activity with
clinical potency -sere cot so conclusive. The main difficulty encountered was
the number of accessory factors which were capable of altering the response of
the organism. Thus, ideally, for a good microbiological assay, the medium
should sustain little or no growth of the microorganism in absence of the
growth factor, end make possible maximum growth in it# presence# In addition
there should tm a. regular increase in response with Increasing increments of
the growth factor until the maximum response is readied. The tests for the
purine and pyrimidine replacing factors are clearly not of this type, i.
they are unduly influenced by the presence of other substances occurring in
the natural extracts which were essayed. Mow that refined preparations are
available of new growth principles, these tee to might prove useful as an aid
in the elucidation of their function in cell metabolism.
The Heuroaoom crassa mutant, in. a medium supplemented with an acidic
fraction of crude liver extract, appeared to be responding to liver prepar-
ations of varying degrees of refinement at concentrations corresponding to
their therapeutic effectiveness, and hence ms considered as a possible test
organist* for the erythrocyte maturation factor. However, it realised
that the preliminary method used would have to be refined and a quantitative
procedure developed. Just at the time this was undertaken bacterial assays
known to be specific for vitamin became available so our search for a
suitable assay organism was dropped is order to pursue the investigation on
the extrinsic-intrinsic phenomenon described in the following section.
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G.
ERYTHEIN AND APOERYTHEN, AND THEIR RELATIONSHIP
TO THE ERYTHROYITE MATURATION FACTOR
le now know that item* of the assay methods outlined in the previous
section, with the possible exception of the one utilising a Manroapora mutant,
responded significantly to the erythrocyte maturation factor (arytarotin or
vitamin £^£ ) and for this reason no did not detect any significant correl-
ation between the microbiological activities arid therapeutic effectiveness,
nor my appreciable activeties of extrinsic factor preparation# by normal
gastric juice. Subsequently, when other microbiological methods which did
respond to vitamin had hem developed both here at the Biochemical
Institute by Dr. Shiva and his coworkers (21S) and in other laboratories
(208) (189), the intrtnsle-cxtrinsic-vitamin relationship was studied
using these organisms*
' Be were very surprised to find that mahsatad normal gastric juice or
extracts of mucosa completely inhibited the growth response
<-O VfF WVUv bt-'jy.
elicited by crythrotin, _ but that tills inhibition could be overcome by adding
an excess of the vitamin. Further exploration of this inactivation revealed
that & protein-like fraction of noiml gastric juice combines with ary throtin
and renders it unavailable to microorganisms, the microbiological tests for
vitamin can, therefore, be easily adapted to quantitative assay nsethod#
for this principle.
the next table outlines the method we found to be most practical in
testing for the erythrotin inactivating factor occurring in normal gastric
♦ The author is vety grateful to Dr* Shi'/© for his generosity la m&klng
available to her staples of his erythrotin concentrates before Vitamin
preparations coaid be obtained from my other source.
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juice and hog Intestinal mucosal extracts* the test organism Is Escherichia
coll* cultivated in a salts-glucose medium supplemented, with vitamins* The
growth of the organism is inhibited by the addition of sulfanilamide, 100 mg*
per liter. Jhe sulfanilamide hinders in some manner the catalytic action
of jj-as&nobens&oic acid in on© of the chemical reactions necessary for the
ultimate synthesis of methionine, fhis inhibition can be overcome (1) by
adding relatively large amounts of j>-€Lminobei*2ioic acid or (f) l>y supplying
the organism* s requirement for methionine in the form of the amino acid
itself, or (S) by supplying the organism with vibasdn The assay for
the inactivating principle (present both in normal gastric juice and ex-
tracts of dried hog duodenal mucosa) is carried out in a medium to which
there has been added just enough erythrotin to overcome the sulfanilamide
inhibition. Increments of the inactivating principle ihieh tie up part or
all of the erytiirotin activity can be detected by the reduction in the
growth response as is illustrated in the following table which records one
of the Initial experiments in which the phenomenon was first observed.*
The union between erv throtin and the inhibiting principle is a thermo-
labile one &s tlie gastric principle produces no inhibition if it is heated
in solution at 100°C* either before or. after it is Maced with eryihroti.ru
Bonce y the samples cannot be antodared, but are added unsterilixed. We
hare encountered no difficulties with bacterial contamination in this reU*
tively simple medium during the short incubation period* When the lacto-
bacilli which respond to vitamin Ikg are used, however, the gastric or
mucosal samples must be sterilised 'ey filtration to avoid, contaminations
whim interfere with the assay, this procedure is not too satisfactory
because some of the vitamin binding activity is either absorbed or des-
troyed. daring the filtration* For this reason, as well as for reasons of
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TABLE XIII
HPICAL MICRDBI0L0GXC--L RESPONSES 10 Ki£
BJHDIKG FACTOR
V1WU- wTia
Organism: Escherichia coll (saline suspension from 84 hour salts-glucose
culture)
Mediums Salis-glueose medium suplesented with vitmlns (815), and 800
mg* sulfanilaxiide par liter
testing
Procedure; 5 si. sampler containing aliquots of normal gastric juice
unheated and heated (100°C#, 10 minutes)
5 ml* of sediuEi
Incubated at 5?°C* for 15 hours
Addendum B? s~ Growth Response in









Milliliters of normal gastric juice (unseated}






Milliliters of normal gastric juice (heated)







simplicity, the Escherichia coll test is to© one of choice*
The foraation of the microbiologically inactive complex effectively
takes place at extreme dilutions as is shown by the fact that the
erythrotin does not even have to be incubated with the protein prior to the
assay but can be mixed with the medium before the medium is aided to the
protein samples* The critical ratio of inhibitory factor to ery throtin is
constant as is shown by the following table in which it can be seen that
every three-fold increase in ery thro tin requires a three-fold increase in
the amount of inhibiting factor necessary to inactivate it* That the in-
hibition resulting from the presence of unheated gastric juice or hog mucosa
can be overcome by addition of stoichiometric amounts of erythrotin rules
out the possibility that the observed effect is the result of proteolytic or
mucolytic activity cf the inactivating principle*
TABLE XIV
A toxic effect of gastric juice upon the growth response of Laeio-
badHug lac Us Dovnev and Lactobacillus leichgtannli had previously been ob-
served, but due to the erratic nature of the response
of these organisms,
B, »
RATIO OF INHIBITOR! FACTOR TO
Testing Proceduret The and cultural conditions described
in Table:! XIII 'were needs tte volume of the samples




inactivating factors Aqueous extract of dried hog duodenal mucosa
(Eli Lilly and Go.).
Growth Response in Galvanometer Deflections
Microrrasus of Mucosal Extract Micro grams of per culture
0 0.5 1.0 5.0 10
\
Q 11 59- 57 42 40
Z 9 38 38 59
10 9 56 37
30 11 11 58
100 IS 14 14 16
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the inactivation of vitamin m& not at first appreciated* Subsequently,
however, the iaaetlvatictt was domosiatinted to occur in an identical fashion
w'mn tease organises are used*
The reaction is a highly specific one and only members of the vitamin
%2 group are l,mac!* The activities of other factors rhieh can be substituted
for this vi basin functionally, but which are chemically unrelated are unaf-
fected* For exmpl&, th* gastric orineiple does not altar the growth response
produced by mUitanim in the Sscherichia coll assay for vitamin nor the
response of purines, folic acid, and the desoxyrites!des (165) (IBS) 167) in
lactobacilli tests,
Brytaeiu (signifying red protein) has been chosen as a suitable chess-
leal imtae for the substance forced when ery throtin la bound by tfao protein
in gastric juice. Apoerythetn, then, designates the protein as it is se-
creted and as it occurs in the secreting imcom prior to it& combination with
crythrotin*
kt ter a partial cimracierlsatton of the cheoieal properties of apoery-
fcfeela had bees a&de, we naturally nere interested in debemlaiug whet, If
my, relationship listed botveea apoerytheta and the intrinsic factor of
Castle* A mraber of lines of evidence led us to postulate feat apaerythein
Is the intrinsic factor, or an important component thereof* First* spoery-
tkein has the chenloal properties ascribed to the -intrinsic factor* It is
a protein, theraol&bilo, non-dialysable, precipitated by alcohol, acetone,
and ammonium sulfate, and inactivated by proteolytic eatyaes* the following
table suamrisea typical results*
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TABLE XV
Secondly* it was reasoned that in vivo apoerytnein undoubtedly combines
with the vitamin components of the diet in a manner comparable to its be-
havior in the nutrient mtihm for bacterial thus apoerythala must in so®
way affect the course of the vitamin during the digestive process*
A third. and sore direct, method of correlating the activity of the
physiologic*;! factor and this chemical substance was made determining the
relative concentrations of apoerythola in the gastric juice of normal patients
and patients with pernicious anemia.
The apoerythaln content of several mmpl®£ collected ftom & normal
subject at different times showed considerable variation* The easiest quan-
titative way to assess the importance of the combining capacity of the gas-
tric juice is in tarns of daily secretion* lamming the average pa.strie se-
cretion of & normal Individual to be a liter end a half a day, we have cal-
culated that, for normal subjects, at least £5 aicrograms of vitamin B could
be bound per day* In the ©nesic patients (with the exception of case f) less
CHEMICAL fmpmn.ES OF APOERlTKEJH
V
gastric Jules SO
Is orml gastric juice, hs* feed
(100 y* IS simiist) 0
soml gastric juice* dialysed
(£4 hours) ca. 40
Filtrate from nor ml gastric juice to vhleh
4 volumes seetone bed h&m added 0
filtrate from Borml gastric juice to iMeh
4 volumes ethanol Lad. been added 0
Filtrate fro® norm! gastric juice *
80% saturated with asasaalua sulfate 0




? J - * hyophilymd mmpl&d obtained- for o# by Br# Edward Campbell of Eli
Lilly and Co*
it aa indebted ’to Dr* Jeromo Ravel for assistance In obtaining this
specimen m well as for other specimen© used in previous exploratory
investigations not reported here*
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-mziimuB comuisQ g&t&gitilb of G&SftilC JO ICE SfelPLES
islllliaicroargtaa .sry fefolia bgatifl







III (pooled samples from
5 subjects)
4*4 80
I? Specimen obtained fro® local
hospital laboratory" 05// 15
Pernicious Aaesda Patients
X Local patient >5
IX (po olcd sampleifro*s
5 subjects)" >5
iu * | 1
IV t S») 1
v « (>>/ >15 ••
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than I*s mierograas can be bound during a twenty four hour laterral# Inasmuch
a© the dally requirement for witaala is considered to be of the order of
1 micr&gr&m per day (172) , and. considering the uon-utillzation of a consider-
able port!on of the apoerythein due to Its destruction by proteolytic enzymes
and due to a failure of a considerable portion of it to contact witaadn
when fee otooaeh is empty, it ie obrious that the pernicious anemia patient
will secret© a» insufficient amount of apoerythetn to bind an adequate amount
of his dietary intake of witaisin to meet his physiological requirement
for tills vitamin (if it mmi be so bound to be utilised)* the normal mbjcot,
on tii© other hand, secretes a 15 to £0 fold excess of the apoerytheta needed
to bind the indicated nlaiaaa daily requirement of vi fcosin B^g*
In addition to the similarity of cheated properties, the specific
nature of the combination, and the correlation between the apoerytheia con-
tent of gastric juice and tbs anemic state, there is a fourth reason for
postulating the identity of this protein factor with the physiological in-
trinsic factor of Castle* This fourth reaeon is based upon studies which
have established the occurrence and distribution of the vitamin biding
factor try means of microbiological assays* Early clinical studies undertook
to localise the secretion site of the intrinsic factor* These early ex-
periments indicated that in swine the site of intrinsic - cior secretion mas
the loser portion of the stomach and the duodenal portion of tbs intestine (s)*
Therefore, the gut of a freshly slaughtered hog e&s analysed If micro biological
techniques for the purpose of finding the distribution of apoerytteia* The
following table indicates that the protein distribution parallel i that pre-
viously determined for tee physiological factor by therapeutic trials.
* Subsequent analyses by Mrs* Dunlap on additional control subjects and
anemic patients sere in line with the findings in the limited number of




# I am deeply indebted to Mrs* !?■ayne Urnlap for determining the dis fcri- \
but!on of apoerythelh- in the gastrointestinal tract of the hog when
Illness prevented my carrying out tills experiment*
Although these four lines of evidence just presented all point to
the identity of the intrinsic factor and apoerythein, conclusive proof mist
await the demonstration that apoerythein possesses therapeutic activity when
used in tm oral treatment of pernicious anemia* The biochemical group of
Eli Lilly and Company which hare cooperated with us in supplying specimen*
are now- sponsoring the clinical trial of concentrate* of the protein.
The complex, erythein, parallels in many respects the behavior of the
biotin-evidin combination* Erythfela decomposes upon. mating arid liberates
a substance which appears to have the asm chemical and biological pro-
perties which "ire possessed by the orythrotin prior to its participation
in the complex formation# Thus It possesses the microbiological activity
of the original ery throtin, it can bo combined with a fresh molecule of
apo@ryihe.in, and on paper chromatographic analysis (using lutidine) it mi-
grates at the tarse rate as ery throtin.
tm APQBKHBKXK OOSTtSt Of A UOG*C3 <&DTBD-IBtMBfXftAL IMC’I
#
MlSSfflgSgg. of..s.fx.waotia , bound
mr _gmm of aeist
Mucosal layer Muscular layer
StttMBh
Cardiac region 0.12 0.08
Fundic region 0.87 0.11






When nora&l gastric juice is used as the apoarythsiii source, the rate
of destruction of spoerytfaeln as measured by its erythrotin inactivating
capacity or the rate of cleavage of the complex corresponds closely to the
rate which has been observed for the inactivation of the intrinsic factor#
However, the inactivation of the mucosal extract ms found to vary to a de-
gree considerably greater than had been anticipated. The presence of ex-
traneous material appears to affect the rate at which the extract loses its
crythrotin combining capacity, and heating for as long as IS minutes at
120° C# may be necessary to completely decompose the complex or prevent
the* mucosa from inactivating any vitamin B #
In spite of the interesting phenomena disclosed by these inves tigatieas,
it is not yet possible to explain the function of apoeryfchein nor the pur-
pose of the extrinsic-intrinsic Interaction* le postulated that through
the complex formation with apoerythain, vitamin w&s protected from des-
truction is the digestive tract* Experiments utilising one sample of gastric
juice did indicate that following apoeryfchein combination the vitamin
activity is less susceptible to destruction by mild alkaline conditions or
dilute oxidising agents* It was therefore* postulated that a possible func-
tion of apoerythein might be the prevention of a comparable destruction in
the digestive tract {257)» Subsequent tests of this hypothesis by my col-
leagues using more- refined preparations of apoerythein derived from bog
mucosa and using a number of other samples of normal gastric juice indicate
that this protective action usually cannot be demonstrated* the results
obtained the first time this hypothesis was tested were probably the effect
of other factors present in the particular gastric juice used, and con-
sequently the activity of the intrinsic factor must’ be attributed to some




In summary, it can be said that this problem has proven interesting
fro® the standpoint of the opportunity it offered for the integration and
©valuation of existing Ideas, as well as the chance to develop sad test
hypotheses of our own.
Fro® a practical standpoint, the final answer to the questions asked
in the introduction to the experimental section have not been obtained.
Certain possibilities have, however, been eliminated, and the probable
identity of the extrinsic factor and a specific protein, apoerythein, has
boon established. The significant results reported here, ares
1. It was shown that the intrinsic factor activity of normal gastric
juice can not be attributed to a counter inhibition of the agents in natural
material which prevent the liberation of folic acid from its conjugates by
conjugate.
2. It was shown that a xanthine or xanthopterin oxldase-lik© action
upon folic acid can not account for the intrinsic factor activity of normal
gastric juice.
3. It was shown that incubating sources of the extrinsic factor with
intrinsic factor premirations caused no significant increase in microbiological
activity when the mixtures were tested in a number of essays which responded
to unidentified factors present in crude liver extracts.
4« Gastric juice was shown to contain a protein, which we have designated
apoervthein. capable of forming with erythrotin (vitamin a thermolsbile
complex, erytheia. in which fora the vitamin is unavailable to those micro-
organisms which require it for growth. We have postulated the Identity of
apoerythein with the intrinsic factor of Castle or an important component thereof
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